SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Evoqua Water Technologies Corp. – ‘10-Q’ for 12/31/19

On:  Tuesday, 2/4/20, at 5:21pm ET   ·   For:  12/31/19   ·   Accession #:  1604643-20-8   ·   File #:  1-38272

Previous ‘10-Q’:  ‘10-Q’ on 8/6/19 for 6/30/19   ·   Next:  ‘10-Q’ on 5/6/20 for 3/31/20   ·   Latest:  ‘10-Q’ on 5/2/23 for 3/31/23   ·   5 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 2/04/20  Evoqua Water Technologies Corp.   10-Q       12/31/19  116:11M

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML    803K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     38K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     38K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     31K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     31K 
52: R1          Document And Entity Information Statement           HTML     56K 
111: R2          Consolidated Balance Sheets                         HTML    164K  
75: R3          Consolidated Balance Sheets Consolidated Balance    HTML     42K 
                Sheets (Parenthetical)                                           
35: R4          Unaudited Consolidated Statements of Operations     HTML     95K 
51: R5          Unaudited Consolidated Statements of Comprehensive  HTML     55K 
                (Loss) Income                                                    
110: R6          Unaudited Consolidated Statements of Changes in     HTML    100K  
                Equity                                                           
72: R7          Unaudited Consolidated Statements of Changes in     HTML    151K 
                Cash Flows                                                       
33: R8          Unaudited Consolidated Statements of Changes in     HTML     31K 
                Cash Flows Unaudited Supplemental Disclosure of                  
                Cash Flow Information (Parenthetical)                            
56: R9          Description of the Company and Basis of             HTML     44K 
                Presentation                                                     
25: R10         Summary of Significant Accounting Policies          HTML    139K 
43: R11         Acquisitions and Divestitures                       HTML     48K 
104: R12         Revenue                                             HTML    116K  
68: R13         Fair Value Measurements                             HTML    150K 
24: R14         Accounts Receivable                                 HTML     38K 
42: R15         Inventories                                         HTML     42K 
103: R16         Property, Plant, and Equipment                      HTML     65K  
67: R17         Goodwill                                            HTML     46K 
26: R18         Debt                                                HTML     79K 
41: R19         Derivative Financial Instruments                    HTML     86K 
102: R20         Product Warranties                                  HTML     55K  
91: R21         Restructuring and Related Charges                   HTML     58K 
21: R22         Employee Benefit Plans                              HTML     45K 
66: R23         Income Taxes                                        HTML     41K 
101: R24         Share-Based Compensation                            HTML     93K  
90: R25         Concentration of Credit Risk                        HTML     35K 
20: R26         Related?Party Transactions                          HTML     33K 
65: R27         Leases                                              HTML    154K 
100: R28         Commitments and Contingencies                       HTML     48K  
92: R29         Accrued Expenses and Other Liabilities              HTML     49K 
70: R30         Business Segments                                   HTML    103K 
105: R31         Earnings per Share                                  HTML     48K  
39: R32         Subsequent Events                                   HTML     32K 
22: R33         Description of the Company and Basis of             HTML    197K 
                Presentation (Policies)                                          
71: R34         Summary of Significant Accounting Policies          HTML    117K 
                (Tables)                                                         
106: R35         Acquisitions and Divestitures (Tables)              HTML     38K  
40: R36         Revenue (Tables)                                    HTML    103K 
23: R37         Fair Value Measurements (Tables)                    HTML    147K 
69: R38         Accounts Receivable (Tables)                        HTML     38K 
107: R39         Inventories (Tables)                                HTML     43K  
83: R40         Property, Plant, and Equipment (Tables)             HTML     69K 
93: R41         Goodwill (Tables)                                   HTML     45K 
63: R42         Debt (Tables)                                       HTML     88K 
18: R43         Derivative Financial Instruments (Tables)           HTML     84K 
84: R44         Product Warranties (Tables)                         HTML     54K 
94: R45         Restructuring and Related Charges (Tables)          HTML     54K 
64: R46         Employee Benefit Plans (Tables)                     HTML     41K 
19: R47         Share-Based Compensation (Tables)                   HTML     84K 
82: R48         Leases (Tables)                                     HTML     85K 
95: R49         Commitments and Contingencies (Tables)              HTML     56K 
112: R50         Accrued Expenses and Other Liabilities (Tables)     HTML     49K  
74: R51         Business Segments (Tables)                          HTML     99K 
37: R52         Earnings per Share (Tables)                         HTML     47K 
53: R53         Description of the Company and Basis of             HTML     61K 
                Presentation (Details)                                           
109: R54         Summary of Significant Accounting Policies          HTML     62K  
                (Details)                                                        
73: R55         Summary of Significant Accounting Policies          HTML     60K 
                (Treated Water Outsourcing) (Details)                            
36: R56         Summary of Significant Accounting Policies (Impact  HTML     87K 
                of ASC Topic 842 Adoption) (Details)                             
50: R57         Acquisitions and Divestitures Narrative (Details)   HTML     71K 
108: R58         Acquisitions and Divestitures Opening Balance       HTML     53K  
                Sheet (Details)                                                  
77: R59         Revenue (Details)                                   HTML     35K 
14: R60         Revenue (Performance Obligation) (Details)          HTML     33K 
61: R61         Revenue (Disaggregation of Revenue) (Details)       HTML     68K 
98: R62         Revenue (Contract Assets and Liabilities)           HTML     65K 
                (Details)                                                        
87: R63         Fair Value Measurements (Details)                   HTML     82K 
13: R64         Fair Value Measurements (Rollforward of Earn-outs)  HTML     58K 
                (Details)                                                        
60: R65         Accounts Receivable (Details)                       HTML     38K 
97: R66         Inventories (Details)                               HTML     45K 
86: R67         Property, Plant, and Equipment (Details)            HTML     55K 
16: R68         Property, Plant, and Equipment Property, Plant and  HTML     43K 
                Equipment (Secured Financing Agreements) (Details)               
57: R69         Goodwill (Details)                                  HTML     31K 
45: R70         Goodwill (Schedule of Goodwill) (Details)           HTML     47K 
30: R71         Debt (Term Facility and Revolving Credit Facility)  HTML     73K 
                (Details)                                                        
79: R72         Debt (Schedule of Long-term Debt) (Details)         HTML     56K 
114: R73         Debt (Long-term Debt Maturities) (Details)          HTML     50K  
46: R74         Debt (Equipment Financing) (Details)                HTML     43K 
31: R75         Debt (Notes Payable) (Details)                      HTML     36K 
80: R76         Debt (Mortgage) (Details)                           HTML     47K 
115: R77         Debt (Schedule of Line of Credit Facilities)        HTML     49K  
                (Details)                                                        
49: R78         Derivative Financial Instruments (Details)          HTML     61K 
28: R79         Derivative Financial Instruments (Fair Values)      HTML     43K 
                (Details)                                                        
44: R80         Derivative Financial Instruments (Amounts           HTML     39K 
                Recognized in AOCI) (Details)                                    
29: R81         Derivative Financial Instruments (Derivatives Not   HTML     39K 
                Designated as Cash Flow Hedges) (Details)                        
78: R82         Derivative Financial Instruments (Amounts           HTML     41K 
                Reclassified out of AOCI) (Details)                              
113: R83         Product Warranties (Details)                        HTML     52K  
47: R84         Restructuring and Related Charges (Details)         HTML     65K 
32: R85         Employee Benefit Plans (Details)                    HTML     44K 
81: R86         Income Taxes (Details)                              HTML     46K 
116: R87         Share-Based Compensation (Details)                  HTML     94K  
48: R88         Share-Based Compensation (Stock Option Activity)    HTML     98K 
                (Details)                                                        
27: R89         Share-Based Compensation (Nonvested Share           HTML     48K 
                Activity) (Details)                                              
15: R90         Share-Based Compensation (RSU Activity) (Details)   HTML     67K 
62: R91         Concentration of Credit Risk (Details)              HTML     38K 
99: R92         Leases (Adoption of ASU 2016-02) (Details)          HTML     53K 
88: R93         Leases (Leases, Lessee Disclosures) (Details)       HTML     68K 
12: R94         Leases (Operating Leases Future Payments)           HTML     54K 
                (Details)                                                        
59: R95         Leases (Finance Lease Assets) (Details)             HTML     34K 
96: R96         Leases (Finance Lease Maturities) (Details)         HTML     52K 
85: R97         Leases (Lessor Operating Lease Future Receivables)  HTML     45K 
                (Details)                                                        
17: R98         Commitments and Contingencies (Schedule of Letters  HTML     52K 
                of Credit and Surety Bonds) (Details)                            
58: R99         Accrued Expenses and Other Liabilities (Details)    HTML     67K 
55: R100        Business Segments (Details)                         HTML     97K 
34: R101        Earnings per Share (Details)                        HTML     62K 
76: R102        Subsequent Events (Details)                         HTML     39K 
89: XML         IDEA XML File -- Filing Summary                      XML    220K 
38: EXCEL       IDEA Workbook of Financial Reports                  XLSX    129K 
 6: EX-101.INS  XBRL Instance -- aqua-20191231                       XML   3.11M 
 8: EX-101.CAL  XBRL Calculations -- aqua-20191231_cal               XML    323K 
 9: EX-101.DEF  XBRL Definitions -- aqua-20191231_def                XML    965K 
10: EX-101.LAB  XBRL Labels -- aqua-20191231_lab                     XML   2.18M 
11: EX-101.PRE  XBRL Presentations -- aqua-20191231_pre              XML   1.48M 
 7: EX-101.SCH  XBRL Schema -- aqua-20191231                         XSD    194K 
54: ZIP         XBRL Zipped Folder -- 0001604643-20-000008-xbrl      Zip    330K 


‘10-Q’   —   Quarterly Report
Document Table of Contents

Page (sequential)   (alphabetic) Top
 
11st Page  –  Filing Submission
"Part I -- Financial Information
"Item 1
"Consolidated Financial Statements
"Consolidated Balance Sheets as of December 31, 2019 (Unaudited) and September 30, 2019
"Unaudited Consolidated Statements of Operations for the Three Months Ended December 31, 2019 and 2018
"Unaudited Consolidated Statements of Comprehensive Income (Loss) for the Three Months Ended December 31, 2019 and 2018
"Unaudited Consolidated Statements of Changes in Equity for the Three Months Ended December 31, 2019 and 2018
"Unaudited Consolidated Statements of Changes in Cash Flow for the Three Months Ended December 31, 2019 and 2018
"Unaudited Supplemental Disclosure of Cash Flow Information for the Three Months Ended December 31, 2019 and 2018
"Notes to Unaudited Consolidated Financial Statements
"Item 2
"Management's Discussion and Analysis of Financial Condition and Results of Operation
"Item 3
"Quantitative and Qualitative Disclosures About Market Risk
"Item 4
"Controls and Procedures
"Part Ii -- Other Information
"Legal Proceedings
"Item 1A
"Risk Factors
"Unregistered Sales of Equity Securities and Use of Proceeds
"Defaults Upon Senior Securities
"Mine Safety Disclosures
"Item 5
"Item 6
"Exhibits

This is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Document  



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 10-Q
ý
 
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the quarterly period ended
or
o
 
Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Commission File Number: 001-38272
 
EVOQUA WATER TECHNOLOGIES CORP.
(Exact name of registrant as specified in its charter)
 
Delaware
(State or other jurisdiction of
incorporation or organization)
 
46-4132761
(I.R.S. Employer Identification No.)

210 Sixth Avenue
Pittsburgh, Pennsylvania
(Address of principal executive offices)
 

15222
(Zip code)
(724) 772-0044
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.01 per share
AQUA
New York Stock Exchange
         Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý   No o
         Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of




this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ý    No o
         Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer o
 
Accelerated filer ý
 
Non-accelerated filer o
(Do not check if a
smaller reporting company)
 
Smaller reporting company o 
Emerging growth company o
         If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
         Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o    No ý
         There were 115,833,974 shares of the registrant’s common stock, par value $0.01 per share, outstanding as of January 31, 2020.





EVOQUA WATER TECHNOLOGIES CORP.
TABLE OF CONTENTS






CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q contains forward‑looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). You can generally identify forward‑looking statements by our use of forward‑looking terminology such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “potential,” “predict,” “projection,” “seek,” “should,” “will” or “would” or the negative thereof or other variations thereon or comparable terminology. In particular, statements about the markets in which we operate, including growth of our various markets, our expectations, beliefs, plans, strategies, objectives, prospects, assumptions, or future events or performance and statements regarding our two-segment restructuring actions and expected restructuring charges and cost savings for fiscal 2020 and beyond contained in this report are forward‑looking statements.
We have based these forward‑looking statements on our current expectations, assumptions, estimates and projections. While we believe these expectations, assumptions, estimates and projections are reasonable, such forward‑looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond our control. These and other important factors, including those discussed in “Item 1A. Risk Factors” of our Annual Report on Form 10-K for the fiscal year ended September 30, 2019, as filed with the Securities and Exchange Commission (“SEC”) on November 25, 2019, and “Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operation” of this Quarterly Report (“Report”) may cause our actual results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by these forward‑looking statements, or could affect our share price. Some of the factors that could cause actual results to differ materially from those expressed or implied by the forward‑looking statements include:
general global economic and business conditions;
our ability to compete successfully in our markets;
our ability to continue to develop or acquire new products, services and solutions and adapt our business to meet the demands of our customers, comply with changes to government regulations and achieve market acceptance with acceptable margins;
our ability to implement our growth strategy, including acquisitions, and our ability to identify suitable acquisition targets;
our ability to operate or integrate any acquired businesses, assets or product lines profitably or otherwise successfully implement our growth strategy;
our ability to achieve the expected benefits of our restructuring actions and restructuring our business into two segments;
material and other cost inflation and our ability to mitigate the impact of inflation by increasing selling prices and improving our productivity efficiencies;
our ability to execute projects in a timely manner, consistent with our customers’ demands;
our ability to accurately predict the timing of contract awards;
delays in enactment or repeals of environmental laws and regulations;
the potential for us to become subject to claims relating to handling, storage, release or disposal of hazardous materials;
risks associated with product defects and unanticipated or improper use of our products;
the potential for us to incur liabilities to customers as a result of warranty claims or failure to meet performance guarantees;
our ability to meet our customers’ safety standards or the potential for adverse publicity affecting our reputation as a result of incidents such as workplace accidents, mechanical failures, spills, uncontrolled discharges, damage to customer or third‑party property or the transmission of contaminants or diseases;

1


litigation, regulatory or enforcement actions and reputational risk as a result of the nature of our business or our participation in large‑scale projects;
seasonality of sales and weather conditions;
risks related to government customers, including potential challenges to our government contracts or our eligibility to serve government customers;
the potential for our contracts with federal, state and local governments to be terminated or adversely modified prior to completion;
risks related to foreign, federal, state and local environmental, health and safety laws and regulations and the costs associated therewith;
risks associated with international sales and operations, including our operations in China;
our ability to adequately protect our intellectual property from third‑party infringement;
our increasing dependence on the continuous and reliable operation of our information technology systems;
risks related to our substantial indebtedness;
our need for a significant amount of cash, which depends on many factors beyond our control;
risks related to AEA Investors LP’s (along with certain of its affiliates, collectively, “AEA”) ownership interest in us; and
other risks and uncertainties, including those listed under “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended September 30, 2019, as filed with the SEC on November 25, 2019, and in other filings we may make from time to time with the SEC.
Given these risks and uncertainties, you are cautioned not to place undue reliance on such forward‑looking statements. The forward‑looking statements contained in this Report are not guarantees of future performance and our actual results of operations, financial condition and liquidity, and the development of the industry in which we operate, may differ materially from the forward‑looking statements contained in this Report. In addition, even if our results of operations, financial condition and liquidity, and events in the industry in which we operate, are consistent with the forward‑looking statements contained in this Report, they may not be predictive of results or developments in future periods.
Any forward‑looking statement that we make in this Report speaks only as of the date of such statement. Except as required by law, we do not undertake any obligation to update or revise, or to publicly announce any update or revision to, any of the forward‑looking statements, whether as a result of new information, future events or otherwise, after the date of this Report.


2


Part I - Financial Information

Item 1. Consolidated Financial Statements

INDEX TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS


3


Evoqua Water Technologies Corp.
Consolidated Balance Sheets
(In thousands)
 
(Unaudited)
 
 
 
 
ASSETS
 
 
 
Current assets
$
682,218

 
$
637,293

Cash and cash equivalents
194,903

 
109,881

Receivables, net
242,036

 
257,585

Inventories, net
148,784

 
137,164

Contract assets
73,909

 
73,467

Prepaid and other current assets
22,586

 
21,940

Assets held for sale

 
37,256

Property, plant, and equipment, net
339,135

 
333,584

Goodwill
397,006

 
392,890

Intangible assets, net
319,665

 
314,767

Deferred income taxes, net of valuation allowance
3,548

 
2,790

Operating lease right-of-use assets, net
42,532

 

Other non‑current assets
26,198

 
25,715

Non-current assets held for sale

 
30,809

Total assets
$
1,810,302

 
$
1,737,848

LIABILITIES AND EQUITY
 
 
 
Current liabilities
$
405,516

 
$
322,221

Accounts payable
134,808

 
144,247

Current portion of debt
113,707

 
13,418

Contract liabilities
43,634

 
39,051

Product warranties
5,131

 
4,922

Accrued expenses and other liabilities
101,656

 
101,839

Income tax payable
6,580

 
4,536

Liabilities held for sale

 
14,208

Non‑current liabilities
989,656

 
1,049,805

Long‑term debt, net of deferred financing fees
851,570

 
951,599

Product warranties
1,471

 
2,332

Obligation under operating leases
32,871

 

Other non‑current liabilities
90,346

 
78,661

Deferred income taxes
13,398

 
13,548

Non-current liabilities held for sale

 
3,665

Total liabilities
1,395,172

 
1,372,026

Commitments and Contingent Liabilities (Note 20)


 


Shareholders’ equity
 
 
 
Common stock, par value $0.01: authorized 1,000,000 shares; issued 117,653 shares, outstanding 115,570 at December 31, 2019; issued 116,008, outstanding 114,344 shares at September 30, 2019
1,170

 
1,154

Treasury stock: 2,083 shares at December 31, 2019 and 1,664 shares at September 30, 2019
(2,837
)
 
(2,837
)
Additional paid‑in capital
560,132

 
552,422

Retained deficit
(123,854
)
 
(174,976
)
Accumulated other comprehensive loss, net of tax
(21,655
)
 
(13,004
)
Total Evoqua Water Technologies Corp. equity
412,956

 
362,759

Non‑controlling interest
2,174

 
3,063

Total shareholders’ equity
415,130

 
365,822

Total liabilities and shareholders’ equity
$
1,810,302

 
$
1,737,848

See accompanying notes to these Unaudited Consolidated Financial Statements

4


Evoqua Water Technologies Corp.
Unaudited Consolidated Statements of Operations
(In thousands except per share data)
 
Three Months Ended
December 31,
 
2019
 
2018
Revenue from product sales
$
196,560

 
$
180,088

Revenue from services
149,545

 
142,914

Revenue from product sales and services
346,105

 
323,002

Cost of product sales
(140,456
)
 
(136,595
)
Cost of services
(99,934
)
 
(97,677
)
Cost of product sales and services
(240,390
)
 
(234,272
)
Gross profit
105,715

 
88,730

General and administrative expense
(45,770
)
 
(54,831
)
Sales and marketing expense
(38,014
)
 
(36,152
)
Research and development expense
(3,684
)
 
(4,146
)
Total operating expenses
(87,468
)
 
(95,129
)
Other operating income
51,720

 
228

Other operating expense
(275
)
 
(188
)
Income (loss) before interest expense and income taxes
69,692

 
(6,359
)
Interest expense
(13,583
)
 
(14,443
)
Income (loss) before income taxes
56,109

 
(20,802
)
Income tax (expense) benefit
(2,603
)
 
4,514

Net income (loss)
53,506

 
(16,288
)
Net income attributable to non‑controlling interest
361

 
442

Net income (loss) attributable to Evoqua Water Technologies Corp.
$
53,145

 
$
(16,730
)
Basic income (loss) per common share
$
0.46

 
$
(0.15
)
Diluted income (loss) per common share
$
0.44

 
$
(0.15
)
See accompanying notes to these Unaudited Consolidated Financial Statements


5


Evoqua Water Technologies Corp.
Unaudited Consolidated Statements of Comprehensive Income (Loss)
(In thousands)
 
Three Months Ended
December 31,
 
2019
 
2018
Net income (loss)
$
53,506

 
$
(16,288
)
Other comprehensive (loss) income
 
 
 
Foreign currency translation adjustments
(8,838
)
 
(1,554
)
Unrealized derivative (loss) gain on cash flow hedges, net of tax
(49
)
 
557

Change in pension liability, net of tax
236

 
96

Total other comprehensive loss
(8,651
)
 
(901
)
Less: Comprehensive income attributable to non‑controlling interest
(361
)
 
(442
)
Comprehensive income (loss) attributable to Evoqua Water Technologies Corp.
$
44,494

 
$
(17,631
)
See accompanying notes to these Unaudited Consolidated Financial Statements


6


Evoqua Water Technologies Corp.
Unaudited Consolidated Statements of Changes in Equity
(In thousands)
 
Three Months Ended December 31, 2019
 
Common Stock
 
Treasury Stock
 
Additional
Paid‑in
Capital
 
Retained
Deficit
 
Accumulated
Other Comprehensive Loss
 
Non‑controlling
Interest
 
Total
 
Shares
 
Cost
 
Shares
 
Cost
 
 
 
 
 
116,008

 
$
1,154

 
1,664

 
$
(2,837
)
 
$
552,422

 
$
(174,976
)
 
$
(13,004
)
 
$
3,063

 
$
365,822

Cumulative effect of adoption of new accounting standards

 

 

 

 

 
(2,023
)
 

 

 
(2,023
)
Equity based compensation expense

 

 

 

 
3,680

 

 

 

 
3,680

Issuance of common stock
120

 
16

 

 

 
4,030

 

 

 

 
4,046

Shares withheld related to net share settlement (including tax withholdings)
1,525

 

 
419

 

 

 

 

 

 

Stock repurchases

 

 

 

 

 

 

 

 

Dividends paid to non-controlling interest

 

 

 

 

 

 

 
(1,250
)
 
(1,250
)
Net income

 

 

 

 

 
53,145

 

 
361

 
53,506

Other comprehensive loss

 

 

 

 

 

 
(8,651
)
 

 
(8,651
)
117,653

 
$
1,170

 
2,083

 
$
(2,837
)
 
$
560,132

 
$
(123,854
)
 
$
(21,655
)
 
$
2,174

 
$
415,130

 
Three Months Ended December 31, 2018
 
Common Stock
 
Treasury Stock
 
Additional
Paid‑in
Capital
 
Retained
Deficit
 
Accumulated
Other Comprehensive Loss
 
Non‑controlling
Interest
 
Total
 
Shares
 
Cost
 
Shares
 
Cost
 
 
 
 
 
115,016

 
$
1,145

 
1,087

 
$
(2,837
)
 
$
533,435

 
$
(163,871
)
 
$
(9,017
)
 
$
3,161

 
$
362,016

Cumulative effect of adoption of new accounting standards

 

 

 

 

 
(1,401
)
 

 

 
(1,401
)
Equity based compensation expense

 

 

 

 
4,525

 

 

 

 
4,525

Issuance of common stock
11

 

 

 

 
68

 

 

 

 
68

Shares withheld related to net share settlement (including tax withholdings)
21

 

 
18

 

 
(15
)
 

 

 

 
(15
)
Dividends paid to non-controlling interest

 

 

 

 

 

 

 
(600
)
 
(600
)
Net (loss) income

 

 

 

 

 
(16,730
)
 

 
442

 
(16,288
)
Other comprehensive loss

 

 

 

 

 

 
(901
)
 

 
(901
)
115,048

 
$
1,145

 
1,105

 
$
(2,837
)
 
$
538,013

 
$
(182,002
)
 
$
(9,918
)
 
$
3,003

 
$
347,404

See accompanying notes to these Unaudited Consolidated Financial Statements


7


Evoqua Water Technologies Corp.
Unaudited Consolidated Statements of Changes in Cash Flows
(In thousands)
 
Three Months Ended
December 31,
 
2019
 
2018
Operating activities
 
 
 
Net income (loss)
$
53,506

 
$
(16,288
)
Reconciliation of net income (loss) to cash flows provided by operating activities:
 
 
 
Depreciation and amortization
25,143

 
23,090

Amortization of debt related costs
701

 
556

Deferred income taxes
(679
)
 
(766
)
Share-based compensation
3,680

 
4,525

Loss (gain) on sale of property, plant and equipment
173

 
(100
)
Gain on sale of business
(58,279
)
 

Foreign currency exchange (gains) losses on intercompany loans and other non-cash items
(6,086
)
 
4,661

Changes in assets and liabilities
 
 
 
Accounts receivable
11,087

 
12,995

Inventories
(14,613
)
 
(20,502
)
Contract assets
3,042

 
7,220

Prepaids and other current assets
(631
)
 
5,988

Accounts payable
(11,056
)
 
(9,143
)
Accrued expenses and other liabilities
(9,378
)
 
(15,394
)
Contract liabilities
4,651

 
12,012

Income taxes
1,388

 
(4,503
)
Other non‑current assets and liabilities
2,083

 
(217
)
Net cash provided by operating activities
4,732

 
4,134

Investing activities
 
 
 
Purchase of property, plant and equipment
(17,572
)
 
(17,569
)
Purchase of intangibles
(210
)
 
(341
)
Proceeds from sale of property, plant and equipment
251

 
237

Proceeds from sale of business, net of cash of $12,117
108,921

 

Acquisitions, net of $0 cash received
(11,160
)
 

Net cash provided by (used in) investing activities
80,230

 
(17,673
)
Financing activities
 
 
 
Issuance of debt, net of deferred issuance costs
3,532

 
4,022

Borrowings under credit facility
13

 
15,000

Repayment of debt
(3,793
)
 
(17,891
)
Repayment of capital lease obligation
(4,162
)
 
(3,285
)
Payment of earn-out related to previous acquisitions
(175
)
 

Proceeds from issuance of common stock
4,046

 
68

Taxes paid related to net share settlements of share-based compensation awards

 
(15
)
Cash paid for interest rate cap

 
(2,235
)
Distribution to non‑controlling interest
(1,250
)
 
(600
)
Net cash used in financing activities
(1,789
)
 
(4,936
)
Effect of exchange rate changes on cash
1,849

 
(724
)
Change in cash and cash equivalents
85,022

 
(19,199
)
Cash and cash equivalents
 
 
 
Beginning of period
109,881

 
82,365

End of period
$
194,903

 
$
63,166

See accompanying notes to these Unaudited Consolidated Financial Statements

8


Evoqua Water Technologies Corp.
Unaudited Supplemental Disclosure of Cash Flow Information
(In thousands)
 
Three Months Ended
December 31,
 
2019
 
2018
Supplemental disclosure of cash flow information
 
 
 
Cash paid for taxes
$
1,382

 
$
1,037

Cash paid for interest
$
12,268

 
$
13,323

Non‑cash investing and financing activities
 
 
 
Finance lease transactions
$
1,782

 
$
2,584

Operating lease transactions
4,734

 

Option and Purchase Right
7,673

 

See accompanying notes to these Unaudited Consolidated Financial Statements

9


Evoqua Water Technologies Corp.
Notes to Unaudited Consolidated Financial Statements
(In thousands)
1. Description of the Company and Basis of Presentation
Background
Evoqua Water Technologies Corp. (referred to herein as the “Company” or “EWT”) was incorporated on October 7, 2013. On January 15, 2014, Evoqua Water Technologies Corp., acquired through its wholly owned entities, EWT Holdings II Corp. and EWT Holdings III Corp. (a/k/a Evoqua Water Technologies), all of the outstanding shares of Siemens Water Technologies, a group of legal entity businesses formerly owned by Siemens AG (“Siemens”). The stock purchase closed on January 15, 2014 and was effective January 16, 2014 (the “Acquisition”). The stock purchase price, net of cash received, was approximately $730,577. On November 6, 2017, the Company completed its initial public offering (“IPO”), pursuant to which an aggregate of 27,777 shares of common stock were sold, of which 8,333 were sold by the Company and 19,444 were sold by the selling shareholders, with a par value of $0.01 per share. After underwriting discounts and commissions and other expenses, the Company received net proceeds from the IPO of approximately $137,605. The Company used a portion of these proceeds to repay $104,936 of indebtedness (including accrued and unpaid interest) under EWT III’s senior secured first lien term loan facility and the remainder for general corporate purposes. The Company did not receive any proceeds from the sale of shares by the selling shareholders. On November 7, 2017, the selling shareholders sold an additional 4,167 shares of common stock as a result of the exercise in full by the underwriters of an option to purchase additional shares. On March 19, 2018, the Company completed a secondary public offering, pursuant to which 17,500 shares of common stock were sold by certain selling shareholders. On March 21, 2018, the selling shareholders sold an additional 2,625 shares of common stock as a result of the exercise in full by the underwriters of an option to purchase additional shares. The Company did not receive any proceeds from the sale of shares by the selling shareholders.
The Business
EWT provides a wide range of product brands and advanced water and wastewater treatment systems and technologies, as well as mobile and emergency water supply solutions and service contract options through its branch network. Headquartered in Pittsburgh, Pennsylvania, EWT is a multi‑national corporation with operations in the United States (“U.S.”), Canada, the United Kingdom (“UK”), the Netherlands, Germany, Australia, the People’s Republic of China, Singapore, the Republic of Korea and India.
The Company is organizationally structured into two reportable operating segments for the purpose of making operational decisions and assessing financial performance: (i) Integrated Solutions and Services and (ii) Applied Product Technologies.
Basis of Presentation
The accompanying Unaudited Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the U.S. (“GAAP”). All intercompany transactions have been eliminated. Unless otherwise specified, all dollar amounts in these notes are referred to in thousands.
The interim Unaudited Consolidated Financial Statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and note disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such SEC rules. We believe that the disclosures made are adequate to make the information presented not misleading. We consistently applied the accounting policies described in our Annual Report on Form 10-K for the fiscal year ended September 30, 2019, as filed with the SEC on November 25, 2019 (“2019 Annual Report”), in preparing these Unaudited Consolidated Financial Statements, with the exception of accounting standard updates described in Note 2, “Summary of Significant Accounting Policies.” These Unaudited Consolidated Financial Statements should be read in conjunction with the audited financial statements and the notes included in our 2019 Annual Report. Certain prior period amounts have been reclassified to conform to the current period presentation.

10


2. Summary of Significant Accounting Policies
Fiscal Year
The Company’s fiscal year ends on September 30.
Use of Estimates
The Unaudited Consolidated Financial Statements have been prepared in conformity with GAAP and require management to make estimates and assumptions. These assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Unaudited Consolidated Financial Statements and the reported amounts of revenue and expenses during the reporting period. Estimates are revised as additional information becomes available. Actual results could differ from these estimates.
Cash and Cash Equivalents
Cash and cash equivalents are liquid investments with an original maturity of three or fewer months when purchased.
Accounts Receivable
Receivables are primarily comprised of uncollected amounts owed to us from transactions with customers and are presented net of allowances for doubtful accounts. Allowances are estimated based on historical write‑offs and the economic status of customers. The Company considers a receivable delinquent if it is unpaid after the term of the related invoice has expired. Write‑offs are recorded at the time all collection efforts have been exhausted.
Inventories
Inventories are stated at the lower of cost or market, where cost is generally determined on the basis of an average or first‑in, first‑out (“FIFO”) method. Production costs comprise direct material and labor and applicable manufacturing overheads, including depreciation charges. The Company regularly reviews inventory quantities on hand and writes off excess or obsolete inventory based on estimated forecasts of product demand and production requirements. Manufacturing operations recognize cost of product sales using standard costing rates with overhead absorption which generally approximates actual cost.
Property, Plant, and Equipment
Property, plant, and equipment is valued at cost less accumulated depreciation. Depreciation expense is recognized using the straight‑line method. Useful lives are reviewed annually and, if expectations differ from previous estimates, adjusted accordingly. Estimated useful lives for major classes of depreciable assets are as follows:
Asset Class
Estimated Useful Life
Machinery and equipment
3 to 20 years
Buildings and improvements
10 to 40 years
Leasehold improvements are depreciated over the shorter of their estimated useful life or the term of the lease. Costs related to maintenance and repairs that do not extend the assets’ useful life are expensed as incurred.
Acquisitions
Acquisitions are recorded using the purchase method of accounting. The purchase price of acquisitions is allocated to the tangible and intangible assets acquired and liabilities assumed based on their estimated fair value at the acquisition date. The excess of the acquisition price over those estimated fair values is recorded as goodwill. Changes to the acquisition date preliminary fair values prior to the expiration of the measurement period, a period not to exceed 12 months from date of acquisition, are recorded as an adjustment to the associated goodwill. Contingent consideration resulting from acquisitions is recorded at its estimated fair value on the acquisition date. These obligations are revalued during each subsequent reporting period and changes in the fair value of the contingent consideration obligations can result from adjustments in the probability of achieving future development steps, sales targets and profitability and are recorded in General and administrative expenses in the Unaudited Consolidated Statements of Operations. Acquisition-related expenses and restructuring costs, if any, are recognized separately from the business combination and are expensed as incurred.

11


Goodwill and Other Intangible Assets
Goodwill represents purchase consideration paid in a business combination that exceeds the value assigned to the net assets of acquired businesses. Other intangible assets consist of customer‑related intangibles, proprietary technology, software, trademarks and other intangible assets. The Company amortizes intangible assets with definite useful lives on a straight‑line basis over their respective estimated economic lives which range from 1 to 26 years.
The Company reviews goodwill to determine potential impairment annually during the fourth quarter of the fiscal year, or more frequently if events and circumstances indicate that the asset might be impaired. Impairment testing for goodwill is performed at a reporting unit level. The quantitative impairment testing utilizes both a market (guideline public company) and income (discounted cash flows) method for determining fair value. In estimating the fair value of the reporting unit, the Company utilized a discounted cash flow (“DCF”) valuation technique, which incorporates judgments and estimates of future cash flows, future revenue and gross profit growth rates, terminal value amount, capital expenditures and applicable weighted‑average cost of capital used to discount these estimated cash flows. The estimates and projections used in the estimate of fair value are consistent with our current budget and long‑range plans, including anticipated change in market conditions, industry trend, growth rates and planned capital expenditures, among other considerations.
Impairment of Long‑Lived Assets
Long‑lived assets, such as property, plant, and equipment, and purchased intangibles subject to amortization, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset or asset group may not be recoverable. Recoverability of the asset or asset group is measured by comparison of its carrying amount to undiscounted future net cash flows the asset or asset group is expected to generate. If the carrying amount of an asset or asset group is not recoverable, the Company recognizes an impairment loss based on the excess of the carrying amount of the asset or asset group over its respective fair value which is generally determined as the present value of estimated future cash flows or as the appraised value.
Assets Held for Sale
Assets and liabilities (the “disposal group”) are classified as held for sale when all of the following criteria are met: (i) the Company commits to a plan to sell the disposal group; (ii) it is unlikely the disposal plan will be significantly modified or discontinued; (iii) the disposal group is available for immediate sale in its present condition; (iv) actions required to complete the sale of the disposal group have been initiated; (v) the sale of the asset is probable and the completed sale is expected to occur within one year; and (vi) the disposal group is actively being marketed for sale at a price that is reasonable given its current market value. Upon classification as held for sale, such assets are no longer depreciated or depleted, and a measurement for impairment is performed to determine if there is any excess of carrying value over fair value less costs to sell. Subsequent changes to estimated fair value less the cost to sell will impact the measurement of assets held for sale if the fair value is determined to be less than the carrying value of the assets.
Debt Issuance Costs and Debt Discounts
Debt issuance costs are capitalized and amortized over the contractual term of the underlying debt using the straight line method which approximates the effective interest method. Debt discounts and lender arrangement fees deducted from the proceeds have been included as a component of the carrying value of debt and are being amortized to interest expense using the effective interest method.
Beginning in the first quarter of 2019, the Company entered into an interest rate cap to mitigate risks associated with the Company’s variable rate debt. See Note 11, “Derivative Financial Instruments” for further details. The Company paid $2,235 as a premium for the interest rate cap, which is being amortized to interest expense over its three-year term. The Company recorded $186 and $62 of premium amortization to interest expense during the three months ended December 31, 2019 and 2018, respectively.
Amortization of debt issuance costs and discounts included in interest expense were $515 and $494 for the three months ended December 31, 2019 and 2018, respectively.


12


Revenue Recognition
The Company adopted Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Topic 606) on October 1, 2018, and recognizes sales of products and services based on the five-step analysis of transactions as provided in Topic 606 which requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for such goods or services.
For sales of aftermarket parts or products with a low level of customization and engineering time, the Company recognizes revenues at the time risks and rewards of ownership pass, which is generally when products are shipped or delivered to the customer as the Company has no obligation for installation. Sales of short‑term service arrangements are recognized as the services are performed, and sales of long‑term service arrangements are typically recognized on a straight‑line basis over the life of the agreement.
For certain arrangements where there is significant customization to the product, the Company recognizes revenue either over time or at a point in time. These products include large capital water treatment projects, systems and solutions for municipal and industrial applications. The nature of the contracts is generally fixed price with milestone billings. The Company recognizes revenue over time if the product has no alternative use and the Company has an enforceable right to payment for the performance completed to date, including a normal profit margin, in the event of termination for convenience. If these two criteria are not met, revenues from these contracts will not be recognized until construction is complete. Contract revenues and cost estimates are reviewed and revised quarterly at a minimum and the cumulative effect of such adjustments are recognized in current operations. The amount of such adjustments have not been material. See Note 4, “Revenue” for further details.
Product Warranties
Accruals for estimated expenses related to warranties are made at the time products are sold and are recorded as a component of Cost of product sales in the Unaudited Consolidated Statements of Operations. The estimated warranty obligation is based on product warranty terms offered to customers, ongoing product failure rates, material usage and service delivery costs expected to be incurred in correcting a product failure, as well as specific obligations for known failures and other currently available evidence. The Company assesses the adequacy of the recorded warranty liabilities on a regular basis and adjusts amounts as necessary.
Leases
The Company accounts for leases in accordance with ASC Topic No. 842, Leases, adopted as of October 1, 2019 (Topic 842). Please see the “Accounting Pronouncements Recently Adopted” section below for information regarding this adoption. See Note 19, “Leases” for further details.
Lessee Accounting
The Company leases office space, buildings, vehicles, forklifts, computers, copiers and other assets under non-cancelable operating and finance leases. The Company determines whether an arrangement is or contains a lease at the inception of the arrangement based on the terms and conditions in the contract. A contract contains a lease if there is an identified asset and the Company has the right to control the asset. If the arrangement contains a lease, the Company recognizes a right-of-use (“ROU”) asset and an operating lease liability as of the lease commencement date. Operating lease assets and finance lease assets are included in Operating lease right-of-use assets, net and Property, plant, and equipment, net, respectively, on the Consolidated Balance Sheets. The corresponding operating lease liabilities are included in Accrued expenses and other liabilities and Obligation under operating leases on the Consolidated Balance Sheets. The corresponding finance lease liabilities are included in Accrued expenses and other liabilities and Other non‑current liabilities on the Consolidated Balance Sheets.
Lessor Accounting
The Company generates revenue through the lease of its water treatment equipment and systems to customers. In certain instances, the Company enters into a contract with a customer but must construct the underlying asset prior to its lease. At the time of contract inception, the Company determines if an arrangement is or contains a lease. Customer contracts that contain a lease are generally classified as operating leases and can contain lease and non-lease components, including

13


maintenance and monitoring services of the Company-owned equipment. As part of the Company’s adoption of Topic 842, the Company has elected the practical expedient for all classes of underlying assets to not separate the lease and non-lease components if certain conditions are met, including the lease qualifying as an operating lease and revenue being recognized in the same pattern for both components. If these conditions are met, the Company will account for the contract with a customer as a combined component under the respective authoritative guidance for the predominant component in the contract.
Shipping and Handling Cost
Shipping and handling costs are included as a component of Cost of product sales.
Derivative Financial Instruments
The Company’s risk-management strategy uses derivative financial instruments to manage interest rate risk and foreign currency exchange rate risk. The Company’s objective in using interest rate derivatives is to add stability to interest expense and manage its exposure to interest rate movements. To accomplish this objective, in November 2018, the Company entered into an interest rate cap which has been designated as a cash flow hedge. The Company uses foreign currency derivative contracts in order to manage the effect of exchange rate fluctuations on forecasted sales and purchases that are denominated in foreign currencies. To mitigate the impact of foreign exchange rate risk, the Company entered into a series of forward contracts designated as cash flow hedges. The Company does not enter into derivatives for trading or speculative purposes. The Company accounts for derivatives and hedging activities in accordance with ASC Topic No. 815, Derivatives and Hedging (ASC 815). The Company recognizes all derivatives on the balance sheet at fair value. Changes in the fair values of derivatives that are not designated as hedges are recognized in earnings. If the derivative is designated and qualifies as a hedge, depending on the nature of the hedge, changes in the fair value of the derivatives are either offset against the change in the hedged assets or liabilities through earnings or recognized in Accumulated other comprehensive income (loss), net of tax (“AOCI”) until the hedged item is recognized in earnings.
Income Taxes
The Company recognizes deferred tax assets and liabilities for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are provided against deferred tax assets when it is deemed more likely than not that some portion or all of the deferred tax asset will not be realized within a reasonable time period. We assess tax positions using a two‑step process. A tax position is recognized if it meets a more‑likely‑than‑not threshold, and is measured at the largest amount of benefit that is greater than 50% percent of being realized. Uncertain tax positions are reviewed each balance sheet date.
Foreign Currency Translation and Transactions
The functional currency for the international subsidiaries is the local currency. Assets and liabilities are translated into U.S. dollars using current rates of exchange, with the resulting translation adjustments recorded in AOCI within shareholders’ equity. Revenues and expenses are translated at the weighted‑average exchange rate for the period, with the resulting translation adjustments recorded in the Unaudited Consolidated Statements of Operations.
Foreign currency translation (gains) losses, mainly related to intercompany loans, which aggregated $(6,443) and $4,815 for the three months ended December 31, 2019 and 2018, respectively, are primarily included in General and administrative expenses in the Unaudited Consolidated Statements of Operations.
Research and Development Costs
Research and development costs are expensed as incurred. The Company recorded $3,684 and $4,146 for the three months ended December 31, 2019 and 2018, respectively.
Equity‑based Compensation
The Company measures the cost of awards of equity instruments to employees based on the grant‑date fair value of the award. The grant‑date fair value of a non-qualified stock option is determined using the Black‑Scholes model. The

14


fair value of restricted stock unit awards is determined using the closing price of our common stock on date of grant. Compensation costs resulting from equity-based payment transactions are recognized primarily within General and administrative expenses, at fair value over the requisite vesting period on a straight-line basis.
Earnings (Loss) Per Share
Basic earnings (loss) per common share is computed based on the weighted average number of shares of common stock outstanding during the period. Diluted earnings per common share is computed based on the weighted average number of shares of common stock, plus the effect of diluted common shares outstanding during the period using the treasury stock method. Diluted potential common shares include outstanding stock options.
Retirement Benefits
The Company applies ASC Topic No. 715, Compensation—Retirement Benefits, which requires the recognition in pension obligations and AOCI of actuarial gains or losses, prior service costs or credits and transition assets or obligations that have previously been deferred. The determination of retirement benefit pension obligations and associated costs requires the use of actuarial computations to estimate participant plan benefits to which the employees will be entitled. The significant assumptions primarily relate to discount rates, expected long‑term rates of return on plan assets, rate of future compensation increases, mortality, years of service, and other factors. The Company develops each assumption using relevant experience in conjunction with market‑related data for each individual country in which such plans exist. All actuarial assumptions are reviewed annually with third‑party consultants and adjusted as necessary. For the recognition of net periodic postretirement cost, the calculation of the expected return on plan assets is generally derived by applying the expected long‑term rate of return on the market‑related value of plan assets. The fair value of plan assets is determined based on actual market prices or estimated fair value at the measurement date.
Treated Water Outsourcing
Treated Water Outsourcing (“TWO”) is a joint venture between the Company and Nalco Water, an Ecolab company, in which the Company holds a 50% partnership interest. The Company is obligated to absorb all risk of loss up to 100% of the joint venture partner’s equity. As such, the Company fully consolidates TWO as a variable interest entity (“VIE”) under ASC Topic No. 810, Consolidation. The Company has not provided additional financial support to this entity which it is not contractually required to provide, and the Company does not have the ability to use the assets of TWO to settle obligations of the Company’s other subsidiaries.
The following provides a summary of TWO’s balance sheet as of December 31, and September 30, 2019, and summarized financial information for the three months ended December 31, 2019 and 2018.
 
 
Current assets (includes cash of $2,739 and $3,903)
$
5,256

 
$
6,324

Property, plant and equipment
1,442

 
2,186

Goodwill
2,206

 
2,206

Other non-current assets
3

 
3

Total liabilities
(2,353
)
 
(2,388
)
 
Three Months Ended
December 31,
 
2019
 
2018
Total revenues
$
2,642

 
$
3,156

Total operating expenses
(1,958
)
 
(2,230
)
Income from operations
$
684

 
$
926

Recent Accounting Pronouncements

15


In November 2018, the Financial Accounting Standards Board (“FASB”) issued ASU 2018-19, Codification Improvements to Topic 326, Financial Instruments—Credit Losses which clarifies that receivables from operating leases are accounted for using the lease guidance and not as financial instruments. ASU 2018-19 will be effective for the Company for the quarter ending December 31, 2020, with early adoptions permitted. The Company is currently assessing the impact of adoption on the Company’s Unaudited Consolidated Financial Statements.
In November 2018, the FASB issued ASU 2018-18, Collaborative Arrangements (Topic 808) Clarifying the Interaction between Topic 808 and Topic 606, which clarifies that certain transactions between collaborative arrangement participants should be accounted for as revenue under Topic 606 when the collaborative arrangement participant is a customer in the context of a unit of account. In addition, unit-of-account guidance in Topic 808 was aligned with the guidance in Topic 606 (that is, a distinct good or service) when an entity is assessing whether the collaborative arrangement or a part of the arrangement is within the scope of Topic 606. ASU 2018-18 should be applied retrospectively to the date of initial adoption of Topic 606 and is effective for the Company for the quarter ending December 31, 2020, with early adoption permitted. The Company is currently assessing the impact of adoption on the Company’s Unaudited Consolidated Financial Statements.
In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Subtopic 820): Disclosure Framework—Changes to the Disclosure Requirements for Fair Value Measurement, which modifies the disclosure requirements on fair value measurements. The amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively for only the most recent interim or annual period presented in the initial year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. ASU 2018-14 will be effective for the Company for the quarter ending December 31, 2020, with early adoption permitted. The Company is currently assessing the impact of adoption on the Company’s disclosures.
In June 2016, the FASB issued ASU 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, amended in November 2019 (ASU 2019-11 and 2019-10), which requires entities to use a new forward-looking “expected loss” model that reflects expected credit losses, including credit losses related to trade receivables, and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates which generally will result in the earlier recognition of allowances for losses. ASU 2016-13 will be effective for the Company for the quarter ending December 31, 2020, with early adoption permitted. The Company does not expect the impact of adoption on the Unaudited Consolidated Financial Statements to be material.
Accounting Pronouncements Recently Adopted
The Company adopted ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, as of October 1, 2019, which simplifies the accounting for income taxes by removing certain exceptions and by clarifying and amending existing guidance in order to improve consistent application of and simplify GAAP for other areas of Topic 740. This adoption did not have an impact on the Company’s Unaudited Consolidated Financial Statements.
The Company adopted ASU 2018‑07, Compensation—Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting, as of October 1, 2019. ASU 2018-07 expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. This adoption did not have an impact on the Company’s Unaudited Consolidated Financial Statements.
The Company adopted ASU 2017‑12, Derivatives and Hedging (Topic 815): Targeted Improvements to Accounting for Hedging Activities, as of October 1, 2019. ASU 2017-12 expands and refines hedge accounting for both nonfinancial and financial risk components and aligns the recognition and presentation of the effects of the hedging instrument and the hedged item in the financial statements and also made certain targeted improvements to simplify the application of hedge accounting guidance and ease the administrative burden of hedge documentation requirements and assessing hedge effectiveness. This adoption did not have a material impact on the Company’s Unaudited Consolidated Financial Statements.
The Company adopted ASU 2016-02, Leases (Topic 842), including associated ASUs related to Topic 842, as of October 1, 2019. ASU No. 2016-02 requires recognition of operating leases as lease assets and liabilities on the balance sheet, and disclosure of key information about leasing arrangements. Amendments to the standard were issued by the FASB in January, July and December 2018, and March 2019 including certain practical expedients, an amendment that provides an additional and optional transition method to adopt the standard at the adoption date and recognize a cumulative-effect adjustment to the opening balance of retained earnings in the period of adoption and certain narrow-scope improvements

16


for lessors. The Company adopted this standard using a modified retrospective approach, applying the new standard to all leases existing at the date of initial adoption and the Company elected to apply the transition requirements at the October 1, 2019 effective date rather than the beginning of the earliest comparative period presented. As a result, the Company recorded a cumulative effect adjustment in the period of adoption, and prior periods were not restated and continue to be reported in accordance with historic accounting under ASC Topic No. 840. In addition, the Company has elected the package of practical expedients permitted under the transition guidance which does not require reassessment of prior conclusions related to contracts containing a lease, lease classification and initial direct lease costs. As an accounting policy election, the Company elected to exclude short-term leases (term of 12 months or less) from the balance sheet and accounts for non-lease and lease components separately for all asset classes. The following table summarizes the impact of adoption to the Consolidated Balance Sheet as of October 1, 2019:
 
As Reported September 30, 2019
 
Impact of Adoption of ASU 2016-02
 
Assets
 
 
 
 
 
Prepaid and other current assets
$
21,940

 
$
(73
)
 
$
21,867

Total current assets
637,293

 
(73
)
 
637,220

Property, plant and equipment, net
333,584

 
2,126

 
335,710

Operating lease right-of-use assets, net

 
42,073

 
42,073

Total Assets
1,737,848

 
44,126

 
1,781,974

Liabilities
 
 
 
 
 
Accrued expenses and other liabilities
101,839

 
13,596

 
115,435

Total current liabilities
322,221

 
13,596

 
335,817

Obligation under operating leases

 
29,308

 
29,308

Other non-current liabilities
78,661

 
3,245

 
81,906

Total non-current liabilities
1,049,805

 
32,553

 
1,082,358

Total liabilities
1,372,026

 
46,149

 
1,418,175

Shareholders' equity
 
 
 
 
 
Retained deficit
(174,976
)
 
(2,023
)
 
(176,999
)
Total Evoqua Water Technologies Corp. equity
362,759

 
(2,023
)
 
360,736

Total shareholder's equity
365,822

 
(2,023
)
 
363,799

Total liabilities and shareholders' equity
$
1,737,848

 
$
44,126

 
$
1,781,974

3. Acquisitions and Divestitures
Acquisitions
Acquisitions support the Company’s strategy of delivering a broad solutions portfolio with robust technology across multiple geographies and end markets. The Company continues to evaluate potential strategic acquisitions of businesses, assets and product lines and believes that capex-like, tuck-in acquisitions present a key opportunity within its overall growth strategy.
On October 1, 2019, the Company acquired a 60% investment position in San Diego-based Frontier Water Systems, LLC (“Frontier”) for $11,160 cash paid at closing. Frontier is a pioneer in the development of patented, engineered equipment packages for high-rate treatment and removal of selenium, nitrate and other metals from complex water systems. During the three months ended December 31, 2019, the Company incurred approximately $326 in acquisition costs, which are included in General and administrative expenses. Frontier is part of the Integrated Solutions and Services segment.

17


The Company has entered into an agreement to purchase the remaining 40% interest in Frontier on or prior to March 30, 2024. This agreement (a) gives holders of the remaining 40% interest in Frontier (the “Minority Owners”) the right to sell to Evoqua up to approximately 10% of the outstanding equity in Frontier at a predetermined price, which right may be exercised by the Minority Owners between January 1, 2021 and February 28, 2021 (the “Option”), and (b) obligates the Company to purchase and the Minority Owners to sell all of the Minority Owners’ remaining interest in Frontier at the fair market value at the time of sale on or prior to March 30, 2024 (the “Purchase Right”). The Purchase Right may be exercised early by the Minority Owners. The agreement to purchase the remaining interest was determined to be financing due to the mandatory Purchase Right, as per ASC Topic 480, Distinguishing Liabilities From Equity, and as such, the Company will recognize a liability for the remaining 40% interest.
The value of the Option was determined to be $506 using a Black Scholes Merton model, and is included within Accrued expenses and other liabilities on the Consolidated Balance Sheets.
The value of the Purchase Right was determined to be $7,167, and is included within Other non‑current liabilities on the Consolidated Balance Sheets, based upon the enterprise value of Frontier upon the acquisition date as per ASC Topic 480, Distinguishing Liabilities From Equity. Pursuant to ASC Topic 480, the Company determined that this should be recorded as a liability and should be recognized at the fair value at the time of inception, adjusted for any consideration or unstated rights or privileges. The liability will be subsequently measured at an amount that would be paid on the reporting date with any change in value from the previous reporting date recognized as interest cost.
The accounting for the acquisition has not yet been completed because the Company has not finalized the valuations of the acquired assets, assumed liabilities and identifiable intangible assets, including goodwill. The preliminary opening balance sheet for Frontier is summarized as follows:
Current assets
$
3,084

Property, plant and equipment
3,824

Goodwill
1,403

Intangible assets
11,516

Total assets acquired
19,827

Liabilities related to Option and Purchase Right
(7,673
)
Other liabilities assumed
(994
)
Net assets acquired
$
11,160

Divestitures
On December 31, 2019, the Company completed the previously-announced sale of the Memcor product line to DuPont de Nemours, Inc. (“DuPont”). The aggregate purchase price paid by DuPont in the Transaction was $110.0 million in cash, subject to certain adjustments. Following adjustments for cash and net working capital, gross proceeds paid by DuPont were $121.3 million. The Company recognized a $49.0 million net pre-tax benefit on the sale of the Memcor product line, net of $8.3 million of discretionary compensation payments to employees in connection with the transaction and $1.0 million in transaction costs incurred in the three months ended December 31, 2019. The Company utilized $100 million of the proceeds from the transaction to repay a portion of the Company’s First Lien Term Loans in January 2020.
4. Revenue

18


Revenue Recognition
The Company recognizes sales of products and services based on the five-step analysis of transactions as provided in Topic 606. For all contracts with customers, the Company first identifies the contract which usually is established when the customer’s purchase order is accepted or acknowledged. Next the Company identifies the performance obligations in the contract. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer. The Company then determines the transaction price in the arrangement and allocates the transaction price to each performance obligation identified in the contract. The Company’s allocation of the transaction price to the performance obligations are based on the relative standalone selling prices for the goods and services contained in a particular performance obligation. The transaction price is adjusted for the Company’s estimate of variable consideration which may include discounts if the Company would fail to meet certain performance requirements, volume discounts or early payment discounts. To estimate variable consideration, the Company utilizes historical experience and known terms. Variable consideration in contracts for the three months ended December 31, 2019 was insignificant.
For sales of aftermarket parts or products with a low level of customization and engineering time, the Company recognizes revenues at the time risks and rewards of ownership pass, which is generally when products are shipped or delivered to the customer as the Company has no obligation for installation. The Company considers shipping and handling services to be fulfillment activities and as such they do not represent separate performance obligations for revenue recognition. Sales of service arrangements are recognized as the services are performed.
For certain arrangements where there is significant customization to the product and for long-term construction-type sales contracts, revenue may be recognized over time. In these instances, revenue is recognized using a measure of progress that applies an input method based on costs incurred in relation to total estimated costs. These arrangements include large capital water treatment projects, systems and solutions for municipal and industrial applications. The nature of the contracts is generally fixed price with milestone billings. In order for revenue to be recognized over a period of time, the product must have no alternative use and the Company must have an enforceable right to payment for the performance completed to date, including a normal profit margin, in the event of termination for convenience. If these two criteria are not met, revenues from these contracts will not be recognized until construction is complete. Instead, revenues from these contracts will be recognized when construction is complete. Contract revenues and cost estimates are reviewed and revised quarterly at a minimum and the cumulative effect of such adjustments are recognized in current operations. The amount of such adjustments have not been material.
The Company has made accounting policy elections to exclude all taxes by governmental authorities from the measurement of the transaction price and that long-term construction-type sales contracts, or those contracts for products with significant customization that the total contract price is less than $100 will be recorded at the point in time when the construction is complete.
Performance Obligations

The Company elects to apply the practical expedient to exclude from this disclosure revenue related to performance obligations if the product has an alternative use and the Company does not have an enforceable right to payment for the performance completed to date, including a normal profit margin, in the event of termination for convenience. The Company maintains a backlog of confirmed orders of approximately $176,693 at December 31, 2019. This backlog represents the aggregate amount of the transaction price allocated to performance obligations that were unsatisfied or partially unsatisfied as of the end of the reporting period. The Company estimates that the majority of these performance obligations will be satisfied within the next twelve months.

The recording of assets recognized from the costs to obtain and fulfill customer contracts primarily relate to the deferral of sales commissions. The Company’s costs incurred to obtain or fulfill a contract with a customer are classified as non-current assets and amortized to expense over the period of benefit of the related revenue. These costs are recorded within Cost of product sales and services. The amount of contract costs was insignificant at December 31, 2019.
The Company offers standard warranties that generally do not represent a separate performance obligation. In certain instances, a warranty is obtained separately from the original equipment sale or the warranty provides incremental services and as such is treated as a separate performance obligation.

19


Disaggregation of Revenue
In accordance with Topic 606, the Company disaggregates revenue from contracts with customers into source of revenue, reportable operating segment and geographical regions. The Company determined that disaggregating revenue into these categories meets the disclosure objective in Topic 606 which is to depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors.
Information regarding the source of revenues:
 
Three Months Ended
December 31,
 
2019
 
2018
Revenue from contracts with customers recognized under Topic 606
$
308,602

 
$
293,004

Other (1)
37,503

 
29,998

Total
$
346,105

 
$
323,002

(1)
Other revenue relates to revenue recognized from Topic 842, Leases, mainly attributable to long term rentals.
Information regarding revenues disaggregated by source of revenue and segment is as follows:
 
Three Months Ended December 31,
 
2019
 
2018
 
Integrated Solutions and Services
 
Applied Product Technologies
 
Total
 
Integrated Solutions and Services
 
Applied Product Technologies
 
Total
Revenue from capital projects
$
54,620

 
$
74,926

 
$
129,546

 
$
43,009

 
$
71,226

 
$
114,235

Revenue from aftermarket
29,673

 
37,341

 
67,014

 
30,796

 
35,057

 
65,853

Revenue from service
143,845

 
5,700

 
149,545

 
136,693

 
6,221

 
142,914

Total
$
228,138

 
$
117,967

 
$
346,105

 
$
210,498

 
$
112,504

 
$
323,002

Information regarding revenues disaggregated by geographic area is as follows:
 
Three Months Ended
December 31,
 
2019
 
2018
United States
$
277,717

 
$
258,718

Europe
26,112

 
21,417

Asia
18,742

 
18,908

Canada
17,563

 
20,303

Australia
5,971

 
3,656

Total
$
346,105

 
$
323,002

Contract Balances
The Company performs its obligations under a contract with a customer by transferring products and/or services in exchange for consideration from the customer. The Company receives payments from customers based on a billing schedule as established in its contracts.
Contract assets relate to costs incurred to perform in advance of scheduled billings. Contract liabilities relate to payments received in advance of performance under the contracts. Change in contract assets and liabilities are due to our performance under the contract.

20



The tables below provides a roll-forward of contract assets and contract liabilities balances for the periods presented:
 
Three Months Ended
December 31,
Contract assets (a)
2019
 
2018
Balance at beginning of period
$
73,467

 
$
69,147

Cumulative effect of adoption of new accounting standards

 
(6,106
)
Recognized in current period
84,596

 
51,567

Reclassified to accounts receivable
(87,046
)
 
(59,305
)
Amounts related to sale of the Memcor product line
2,710

 

Foreign currency
182

 
345

Balance at end of period
$
73,909

 
$
55,648

(a)
Excludes receivable balances which are disclosed on the Consolidated Balance Sheets.
 
Three Months Ended
December 31,
Contract Liabilities
2019
 
2018
Balance at beginning of period
$
39,051

 
$
17,652

Cumulative effect of adoption of new accounting standards

 
1,773

Recognized in current period
88,616

 
67,852

Amounts in beginning balance reclassified to revenue
(37,624
)
 
(15,825
)
Current period amounts reclassified to revenue
(46,083
)
 
(40,709
)
Amounts related to sale of the Memcor product line
(700
)
 

Foreign currency
374

 
346

Balance at end of period
$
43,634

 
$
31,089

5. Fair Value Measurements
As of December 31, and September 30, 2019, the fair values of cash and cash equivalents, accounts receivable and accounts payable approximate carrying values due to the short maturity of these items.
The Company measures the fair value of pension plan assets and liabilities, deferred compensation plan assets and liabilities on a recurring basis pursuant to ASC Topic No. 820, Fair Value Measurement. ASC Topic No. 820 establishes a three‑tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. These tiers include:
Level 1: Quoted prices for identical instruments in active markets.
Level 2: Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model‑derived valuations whose inputs are observable or whose significant value driver is observable.
Level 3: Unobservable inputs in which little or no market data is available, therefore requiring an entity to develop its own assumptions.
The following table presents the Company’s financial assets and liabilities at fair value. The fair values related to the pension plan assets are determined using net asset value (“NAV”) as a practical expedient, or by information categorized in the fair value hierarchy level based on the inputs used to determine fair value. The reported carrying amounts of deferred compensation plan assets and liabilities and debt approximate their fair values. The Company uses interest rates and other

21


relevant information generated by market transactions involving similar instruments to fair value these assets and liabilities, therefore all are classified as Level 2 within the valuation hierarchy.
 
Net Asset Value
 
Quoted Market
Prices in Active
Markets (Level 1)
 
Significant Other
Observable Inputs
(Level 2)
 
Significant
Unobservable Inputs
(Level 3)
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
Pension plan
 
 
 
 
 
 
 
Cash
$

 
$
15,054

 
$

 
$

Government Securities
2,034

 

 

 

Liability Driven Investment
5,379

 

 

 

Guernsey Unit Trust
1,072

 

 

 

Global Absolute Return
2,103

 

 

 

Deferred compensation plan assets
 
 
 
 
 
 
 
Trust Assets

 
90

 

 

Insurance

 

 
19,124

 

Interest rate cap

 

 
5

 

Foreign currency forward contracts

 

 
148

 

Liabilities:
 
 
 
 
 
 
 
Pension plan

 

 
(44,667
)
 

Deferred compensation plan liabilities

 

 
(21,874
)
 

Long‑term debt

 

 
(979,691
)
 

Foreign currency forward contracts

 

 
(123
)
 

Earn-outs related to acquisitions

 

 

 
(91
)
Option and Purchase Right

 

 

 
(7,673
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
Pension plan
 
 
 
 
 
 
 
Cash
$

 
$
14,607

 
$

 
$

Government Securities
4,703

 

 

 

Liability Driven Investment
3,261

 

 

 

Guernsey Unit Trust
997

 

 

 

Global Absolute Return
1,957

 

 

 

Deferred compensation plan assets
 
 
 
 
 
 
 
Trust Assets

 
16

 

 

Insurance

 

 
18,684

 

Interest rate cap

 

 
19

 

Foreign currency forward contracts

 

 
278

 

Liabilities:
 
 
 
 
 
 
 
Pension plan

 

 
(42,948
)
 

Deferred compensation plan liabilities

 

 
(21,318
)
 

Long‑term debt

 

 
(979,357
)
 

Foreign currency forward contracts

 

 
(154
)
 

Earn-outs related to acquisitions

 

 

 
(1,545
)
The pension plan assets and liabilities and deferred compensation plan assets and liabilities are included in other non-current assets and other non-current liabilities at December 31, and September 30, 2019.

22


The Company records contingent consideration arrangements at fair value on a recurring basis and the associated balances presented as of December 31, and September 30, 2019 are earn-outs related to acquisitions. The fair value of earn-outs related to acquisitions is based on significant unobservable inputs including the achievement of certain performance metrics. Significant changes in these inputs would result in corresponding increases or decreases in the fair value of the earn-out each period until the related contingency has been resolved. Changes in the fair value of the contingent consideration obligations can result from adjustments in the probability of achieving future development steps, sales targets and profitability and are recorded in General and administrative expenses in the Unaudited Consolidated Statements of Operations.
A roll-forward of the activity in the Company’s fair value of earn-outs related to acquisitions is as follows:
 
Current Portion (1)
 
Long-term Portion (2)
 
Total
$
611

 
$
934

 
$
1,545

Payments
(187
)
 

 
(187
)
Fair value adjustment
(333
)
 
(934
)
 
(1,267
)
$
91

 
$

 
$
91

(1)
Included in Accrued expenses and other liabilities on the Consolidated Balance Sheets.
(2)
Included in Other non‑current liabilities on the Consolidated Balance Sheets.
Pursuant to the acquisition of Frontier, the Company recorded a liability for the Option and Purchase Right
to purchase the remaining
40% interest. The fair value of the options is based upon significant unobservable inputs including future earnings and other market factors. Significant changes in these inputs would result in corresponding increases or decreases in the fair value of the options each period until the purchase of the remaining 40% interest has occurred. Changes in the fair value can result from earnings achieved over the passage of time and will be recorded in Interest expense in the Unaudited Consolidated Statements of Operations. As of December 31, 2019, $506 is included in Accrued expenses and other liabilities related to the Option and $7,167 is included in Other non‑current liabilities related to the Purchase Right on the Consolidated Balance Sheets.
6. Accounts Receivable
Accounts receivable are summarized as follows:
 
 
Accounts receivable
$
247,178

 
$
262,491

Allowance for doubtful accounts
(5,142
)
 
(4,906
)
Receivables, net
$
242,036

 
$
257,585

7. Inventories
The major classes of Inventories, net are as follows:
 
 
Raw materials and supplies
$
78,127

 
$
75,223

Work in progress
16,712

 
14,741

Finished goods and products held for resale
64,184

 
58,223

Costs of unbilled projects
3,655

 
2,347

Reserves for excess and obsolete
(13,894
)
 
(13,370
)
Inventories, net
$
148,784

 
$
137,164


23


8. Property, Plant, and Equipment
Property, plant, and equipment consists of the following:
 
 
Machinery and equipment
$
332,109

 
$
316,390

Rental equipment
178,069

 
172,534

Land and buildings
64,761

 
64,165

Construction in process
44,516

 
40,599

 
619,455

 
593,688

Less: accumulated depreciation
(280,320
)
 
(260,104
)
 
$
339,135

 
$
333,584

The Company entered into secured financing agreements that require providing a security interest in specified equipment. As of December 31, and September 30, 2019, the gross and net amounts of those assets are as follows:
 
 
 
Gross
 
Net
 
Gross
 
Net
Machinery and equipment
$
52,395

 
$
45,333

 
$
48,288

 
$
42,162

Construction in process
1,494

 
1,494

 
2,531

 
2,531

 
$
53,889

 
$
46,827

 
$
50,819

 
$
44,693

Depreciation expense and maintenance and repairs expense for the three months ended December 31, 2019 and 2018 were as follows:
 
Three Months Ended
December 31,
 
2019
 
2018
Depreciation expense
$
17,303

 
$
15,209

Maintenance and repair expense
6,065

 
6,157

9. Goodwill
Changes in the carrying amount of goodwill are as follows:
 
Integrated Solutions and Services
 
Applied Product Technologies
 
Total
$
222,013

 
$
170,877

 
$
392,890

Business combinations and divestitures
1,403

 
(237
)
 
1,166

Measurement period adjustment

 
298

 
298

Foreign currency translation
863

 
1,789

 
2,652

$
224,279

 
$
172,727

 
$
397,006

As of December 31, and September 30, 2019, $152,099 and $151,880, respectively, of goodwill was deductible for tax purposes.

24


10. Debt
Long‑term debt consists of the following:
 
 
First Lien Term Loan, due December 20, 2024
$
926,384

 
$
928,753

Revolving Credit Facility

 

Equipment Financing, due June 30, 2024 to July 5, 2029
48,096

 
45,960

Notes Payable, due July 31, 2023
759

 
807

Mortgage, due June 30, 2028
1,661

 
1,635

Total debt
976,900

 
977,155

Less unamortized discount and lender fees
(11,623
)
 
(12,138
)
Total net debt
965,277

 
965,017

Less current portion
(113,707
)
 
(13,418
)
Total long‑term debt
$
851,570

 
$
951,599

Term Facilities and Revolving Credit Facility
On January 15, 2014, EWT Holdings III Corp. (“EWT III”), an indirect wholly-owned subsidiary of the Company, entered into a First Lien Credit Agreement and Second Lien Credit Agreement (the “Credit Agreements” or, after the prepayment and termination of the Second Lien Credit Agreement, the “First Lien Credit Agreement” or “Credit Agreement”) among EWT III, EWT Holdings II Corp., the lenders party thereto and Credit Suisse AG as administrative agent and collateral agent. The First Lien Credit Agreement provided for a seven-year term loan facility, and the Second Lien Credit Agreement provided for an eight-year term loan facility. The term loan facilities originally consisted of the “First Lien Term Loan” and “Second Lien Term Loan” in aggregate principal amounts of $505,000 and $75,000, respectively. The First Lien Credit Agreement also made available to the Company a $75,000 revolving credit facility (the “Revolver”), which provided for a letter of credit sub-facility up to $35,000.

During fiscal years 2017 and 2018, certain subsidiaries of the Company entered into amendments to the Credit Agreement which provided for, among other things, the refinancing of the term loans, extension of the maturity date to December 20, 2024, the reduction in the interest rate spreads to 3.00% and an additional $150,000 borrowed in incremental term loans. In addition, the revolving credit commitment and letters of credit sublimit was increased to $125,000 and $45,000, respectively. The Company makes quarterly principal payments of $2,369. At December 31, 2019, the interest rate on borrowings was 4.70%, comprised of 1.70% LIBOR plus the 3.00% spread.

Total deferred fees related to the First Lien Term Loan were $11,623 and $12,138, net of amortization, as of December 31, and September 30, 2019, respectively. These fees were included as a contra liability to debt on the Consolidated Balance Sheets.

The following summarizes the Company’s outstanding borrowings under the Revolver and outstanding letters of credit as of December 31, and September 30, 2019, respectively.
 
 
Borrowing availability under the Revolver
$
125,000

 
$
125,000

Outstanding borrowings under the Revolver

 

Outstanding letters of credit under the Revolver
13,088

 
12,956

Unused amounts under the Revolver
$
111,912

 
$
112,044

 
 
 
 
Additional letters of credit under a separate arrangement
$
194

 
$
204


25


The First Lien Credit Agreement contains limitations on incremental borrowings, is subject to leverage ratios and allows for optional prepayments. Under certain circumstances, the Company may be required to remit excess cash flows as defined based upon exceeding certain leverage ratios. The Company did not exceed such ratios during the three months ended December 31, 2019, does not anticipate exceeding such ratios during the year ending September 30, 2020, and therefore does not anticipate any additional repayments during the year ending September 30, 2020.

Equipment Financing
As of December 31, and September 30, 2019, the Company had equipment financings in an aggregate outstanding amount of $48,096 and $45,960, with interest rates ranging from 5.02% to 8.07%, and due dates ranging from June 30, 2024 to July 5, 2029.
Notes Payable
As of December 31, and September 30, 2019, the Company had notes payable in an aggregate outstanding amount of $759 and $807, with an interest rates of 6.53%, and a due date of July 31, 2023. These notes are related to certain equipment related contracts and are secured by the underlying equipment and assignment of the related contracts.
Mortgage
On June 29, 2018, the Company's subsidiary MAGNETO special anodes B.V. entered into a 10-year mortgage agreement for €1,600 ($1,796) to finance a facility in the Netherlands, subject to monthly principal payments of €7 ($7) at a blended interest rate of 2.4% with maturity in June 2028. The Company had $1,661 and $1,635 principal outstanding under this facility at December 31, and September 30, 2019, respectively.
Repayment Schedule
Aggregate maturities of all long‑term debt, including current portion of long‑term debt and excluding finance lease obligations as of December 31, 2019, are presented below:
Fiscal Year
 
Remainder of 2020
$
110,264

2021
13,839

2022
14,057

2023
14,228

2024
14,114

Thereafter
810,398

Total
$
976,900

11. Derivative Financial Instruments
Interest Rate Risk Management
    The Company is subject to market risk exposure arising from changes in interest rates on our senior secured credit facilities, which bear interest at rates that are indexed against LIBOR. The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to mitigate its exposure to rising interest rates. To accomplish these objectives, the Company entered into an interest rate cap, designated as a cash flow hedge, to mitigate risks associated with variable rate debt effective November 28, 2018. The LIBOR interest rate cap covers a notional amount of $600,000 of the Company’s senior secured debt, is effective for a period of three years and has a strike rate of 3.5%. Interest rate caps designated as cash flow hedges involve the receipt of stipulated amounts from a counterparty if interest rates rise above the strike rate defined in the contract. The premium paid for the interest rate cap was $2,235 and is being amortized to interest expense over its three-year term using the caplet method. At December 31, and September 30, 2019, the unamortized premium was $1,428 and $1,614, respectively, of which $683 and $869, respectively, is included in Other non‑current assets

26


and the remaining $745 is included in Prepaid and other current assets. The Company recorded $186 and $62 of premium amortization to interest expense during the three months ended December 31, 2019 and 2018, respectively.
Foreign Currency Risk Management
The Company’s functional currency is the U.S. dollar. By operating internationally, the Company is subject to foreign currency risk from transactions denominated in currencies other than the U.S. dollar (“foreign currencies”). To mitigate cross-currency transaction risk, the Company analyzes significant exposures where it has receipts or payments in a currency other than the functional currency of its operations, and from time to time may strategically enter into short-term foreign currency forward contracts to lock in some or all of the cash flows associated with these transactions. The Company is also subject to currency translation risk associated with converting the foreign operations’ financial statements into U.S. dollars. The Company uses foreign currency derivative contracts in order to manage the effect of exchange fluctuations on forecasted sales and purchases that are denominated in foreign currencies. To mitigate the impact of foreign exchange rate risk, the Company entered into a series of forward contracts designated as cash flow hedges. As of December 31, 2019, the notional amount of the forward contracts held to sell foreign currencies was $9,516.
Credit Risk Management
The counterparties to the Company’s derivative contracts are highly rated financial institutions. The Company regularly reviews the creditworthiness of its financial counterparties and does not expect to incur a significant failure of any counterparties to perform under any agreements. The Company is not subject to any obligations to post collateral under derivative instrument contracts. The Company records all derivative instruments on a gross basis in the Consolidated Balance Sheets. Accordingly, there are no offsetting amounts that net assets against liabilities.
Derivatives Designated as Cash Flow Hedges
The Company accounts for derivatives and hedging activities in accordance with ASC Topic No. 815, “Derivatives and Hedging” (Topic No. 815). As required by Topic No. 815, the Company records all derivatives on the balance sheet at fair value and adjusts to market on a quarterly basis. The Company’s interest rate cap is valued based on readily observable market inputs, such as quotations on interest rates and LIBOR yield curves at the reporting date. The Company’s foreign currency forward contracts are valued based on quoted forward foreign exchange prices and spot rates at the reporting date. For a derivative that is designated as a cash flow hedge, changes in the fair value of the derivative are recognized in AOCI until the hedged item affects earnings. The Company does not use derivative financial instruments for trading or speculative purposes.
The following represents the fair value recorded for derivatives designated as cash flow hedges for the periods presented:
 
 
 
Asset Derivatives
 
Balance Sheet Location
 
 
Interest rate cap
Prepaid and other current assets
 
$
5

 
$
19

Foreign currency forward contracts
Prepaid and other current assets
 
148

 
269

 
 
 
Liability Derivative
 
Balance Sheet Location
 
 
Foreign currency forward contracts
Accrued expenses and other current liabilities
 
$
68

 
$
154


27


The following represents the amount of (loss) gain recognized in AOCI (net of tax) during the periods presented:
 
Three Months Ended
December 31,
 
2019
 
2018
Interest rate cap
$
(14
)
 
$
780

Foreign currency forward contracts
19

 
(334
)
The following represents the amount of (loss) gain reclassified from AOCI into earnings during the periods presented:
 
 
 
Three Months Ended
December 31,
 
Location of (Loss) Gain
 
2019
 
2018
Foreign currency forward contracts
Cost of product sales and services
 
$

 
$
(126
)
Foreign currency forward contracts
General and administrative expense
 
54

 

Foreign currency forward contracts
Research and development expense
 

 
15

 
 
 
$
54

 
$
(111
)
Based on the fair value amounts of the Company’s cash flow hedges at December 31, 2019, the Company expects that approximately $97 of pre-tax net losses will be reclassified from AOCI into earnings during the next twelve months. The amount ultimately realized, however, will differ as exchange rates vary and the underlying contracts settle. In addition, $745 of caplet amortization will be amortized into interest expense during the next twelve months.
Derivatives Not Designated as Cash Flow Hedges
The following represents the fair value recorded for derivatives not designated as cash flow hedges for the periods presented:
 
 
 
Asset Derivative
 
Balance Sheet Location
 
 
Foreign currency forward contracts
Prepaid and other current assets
 
$

 
$
9

 
 
 
Liability Derivative
 
Balance Sheet Location
 
 
Foreign currency forward contracts
Accrued expenses and other current liabilities
 
$
55

 
$

12. Product Warranties
The Company accrues warranty obligations associated with certain products as revenue is recognized. Provisions for the warranty obligations are based upon historical experience of costs incurred for such obligations, adjusted for site‑specific risk factors, and, as necessary, for current conditions and factors. There are significant uncertainties and judgments involved in estimating warranty obligations, including changing product designs, differences in customer installation processes and future claims experience which may vary from historical claims experience.

28


A reconciliation of the activity related to the accrued warranty, including both the current and long‑term portions, is as follows:
 
Current Product Warranties
 
Non-Current Product Warranties
 
Three Months Ended
December 31,
 
Three Months Ended
December 31,
 
2019
 
2018
 
2019
 
2018
Balance at beginning of the period
$
4,922

 
$
8,907

 
$
2,332

 
$
3,360

Warranty provision for sales
1,251

 
1,373

 
44

 
300

Settlement of warranty claims
(1,989
)
 
(1,428
)
 
(1,076
)
 

Amounts related to sale of the Memcor product line
795

 

 
135

 

Foreign currency translation and other
152

 
124

 
36

 
(4
)
Balance at end of the period
$
5,131

 
$
8,976

 
$
1,471

 
$
3,656

13. Restructuring and Related Charges
To better align its resources with its growth strategies and reduce the cost structure, the Company commits to restructuring plans as necessary. The Company has undertaken various restructuring initiatives, including the wind-down of the Company’s operations in Italy, restructuring of the Company’s operations in Australia, consolidation of functional support structures on a global basis, and consolidation of the Singaporean research and development center.

On October 30, 2018, the Company announced a transition from a three-segment structure to a two-segment operating model designed to better serve the needs of customers worldwide. This new structure was effective October 1, 2018 and combined the Municipal services business with the former Industrial segment into a new segment, Integrated Solutions and Services, a group entirely focused on engaging directly with end users. The former Products segment and Municipal products businesses have been combined into a new segment, Applied Product Technologies, which is focused on developing product platforms to be sold primarily through third party channels. The Company expects to incur approximately $3 million of cash costs through fiscal 2020 as a result of this transition related to other non-employee related business optimizations.
The table below sets forth the amounts accrued for the restructuring components and related activity:
 
Three Months Ended
December 31,
 
2019
 
2018
Balance at beginning of the period
$
655

 
$
710

Restructuring charges related to two-segment realignment
675

 
1,945

Restructuring charges related to other initiatives
245

 
989

Write off charge and other non‑cash activity
(53
)
 
(5)

Cash payments
(1,156)

 
(2,664)

Other adjustments
(1
)
 
(16)

Balance at end of the period
$
365

 
$
959

The balances for accrued restructuring liabilities at December 31, and September 30, 2019, are recorded in Accrued expenses and other liabilities on the Consolidated Balance Sheets. Restructuring charges primarily represent severance charges. The Company expects to pay the remaining amounts accrued as of December 31, 2019 during the first half of 2020.

29


The table below sets forth the location of amounts recorded above on the Unaudited Consolidated Statements of Operations:
 
Three Months Ended
December 31,
 
2019
 
2018
Cost of product sales and services
$
384

 
$
698

General and administrative expense
480

 
2,028

Sales and marketing expense
3

 
203


$
867

 
$
2,929

The Company continues to evaluate restructuring activities that may result in additional charges in the future.
14. Employee Benefit Plans
The Company maintains multiple employee benefit plans.
Certain of the Company’s employees in the UK were participants in a Siemens defined benefit plan established for employees of a UK-based operation acquired by Siemens in 2004. The plan was frozen with respect to future service credits for active employees, however the benefit formula recognized future compensation increases. The Company agreed to establish a replacement defined benefit plan, with the assets of the Siemens scheme transferring to the new scheme on April 1, 2015.
The Company’s employees in Germany also participate in a defined benefit plan. Assets equaling the plan’s accumulated benefit obligation were transferred to a German defined benefit plan sponsored by the Company upon the acquisition of EWT from Siemens. The German entity also sponsors a defined benefit plan for a small group of employees located in France.
The components of net periodic benefit cost for the plans were as follows:
 
Three Months Ended
December 31,
 
2019
 
2018
Service cost
$
261

 
$
217

Interest cost
68

 
119

Expected return on plan assets
(30
)
 
(30
)
Amortization of actuarial losses
236

 
96

Pension expense for defined benefit plans
$
535

 
$
402

The components of pension expense, other than the service cost component which is included in General and administrative expense, are included in the line item Other operating expense in the Unaudited Consolidated Statements of Operations.
15. Income Taxes
The income tax provision for interim periods is comprised of tax on ordinary income (loss) provided at the most recent projected annual effective tax rate (“PAETR”), adjusted for the tax effect of discrete items. Management estimates the PAETR each quarter based on the forecasted annual pretax income or (loss). The Company is required to reduce deferred tax assets by a valuation allowance if, based on all available evidence, it is considered more likely than not that some portion or all of the benefit of the deferred tax assets will not be realized in future periods. The Company also records the income tax impact of certain discrete, unusual or infrequently occurring items including changes in judgment about valuation allowances and effects of changes in tax laws or rates, in the interim period in which they occur.

30


When a company maintains a valuation allowance in a particular jurisdiction, no net deferred income tax expense or (benefit) will typically be provided. Jurisdictions with projected income that maintain a valuation allowance typically will form part of the PAETR calculation discussed above. However, jurisdictions with a projected loss for the year that maintain a valuation allowance are excluded from the PAETR calculation. Instead, the income tax for these jurisdictions is computed separately.
The actual year-to-date income tax expense (benefit) is the product of the most current PAETR and the actual year-to-date pretax income (loss) adjusted for any discrete tax items. The income tax expense (benefit) for a particular quarter, except for the first quarter, is the difference between the year-to-date calculation of income tax expense (benefit) and the year-to-date calculation for the prior quarter. Items unrelated to current period ordinary income or (loss) are recognized entirely in the period identified as a discrete item of tax. Discrete items generally relate to changes in tax laws, adjustments to prior period’s actual liability determined upon filing tax returns, and adjustments to previously recorded reserves for uncertain tax positions, initially recording or fully reversing valuation allowances. The inclusion of discrete items in a particular quarter can cause the actual effective rate for that quarter to vary significantly from the PAETR.
Therefore, the actual effective income tax rate for a particular quarter can vary significantly based upon the jurisdictional mix and timing of actual earnings compared to projected annual earnings, permanent items, earnings for those jurisdictions that maintain a valuation allowance, tax associated with jurisdictions excluded from the PAETR calculation and discrete items.
Annual Effective Tax Rate
The PAETR, which excludes the impact of discrete items, was 4.9% and 25.8% as of the three months ended December 31, 2019 and 2018, respectively. For the three months ended December 31, 2019, the PAETR of 4.9% was lower than the U.S federal statutory rate of 21.0% primarily due to the gain on the sale of the Memcor product line, the U.S. valuation allowance provided on U.S. deferred tax assets as well as the impact of deferred tax liabilities related to indefinite lived intangibles, a portion of which were reversed in relation to the sale of the Memcor product line.
The Company continues to maintain a full valuation on U.S. federal and state net deferred tax assets (excluding the tax effects of deferred tax liabilities associated with indefinite lived intangibles) for the year ending September 30, 2020 as a result of pretax losses incurred since the Company’s inception in early 2014. The Company reported positive pre-tax earnings for the first time in 2017 and is projecting positive pre-tax earnings in 2020, however, the Company generated pre-tax losses in all other years. Management believes it is prudent to retain a valuation allowance until a more consistent pattern of earnings is established and net operating loss carryforwards begin to be utilized.
Prior and Current Period Tax Expense
For the three months ended December 31, 2019, the Company recognized income tax expense of $2,603 on pretax income of $56,109. The rate of 4.6% differed from the U.S. statutory rate of 21.0% principally due to the gain on the sale of the Memcor product line which did not generate significant tax expense due to the combination of the U.S. valuation allowance and favorable foreign tax regimes, as well as the favorable impact of the reversal of a portion of deferred tax liabilities related to indefinite lived intangibles.
For the three months ended December 31, 2018, the Company recognized an income tax benefit of $4,514 on a pretax loss of $20,802. Discrete items for the quarter were not material.
At December 31, 2019, the Company had gross unrecognized tax benefits of $1,289.
16. Share-Based Compensation
The Company designs equity compensation plans to attract and retain employees while also aligning employees’ interests with the interests of the Company’s shareholders. In addition, members of the Company’s Board of Directors (the “Board”) participate in equity compensation plans in connection with their service on the Company’s Board.

The Company established the Evoqua Water Technologies Corp. Stock Option Plan (the “Stock Option Plan”)

31


shortly after the acquisition date of January 16, 2014. The plan allows certain management employees and the Board to purchase shares in Evoqua Water Technologies Corp. Under the Stock Option Plan, the number of shares available for award was 11,083. As of December 31, 2019, there were approximately 1,704 shares available for future grants, however, the Company does not currently intend to make additional grants under the Stock Option Plan.    
In connection with the IPO, the Board adopted and the Company’s stockholders approved the Evoqua Water Technologies Corp. 2017 Equity Incentive Plan (or the “Equity Incentive Plan”), under which equity awards may be made in the respect of 5,100 shares of common stock of the Company. Under the Equity Incentive Plan, awards may be granted in the form of options, restricted stock, restricted stock units, stock appreciation rights, dividend equivalent rights, share awards and performance-based awards (including performance share units and performance-based restricted stock). As of December 31, 2019, there were approximately 2,049 shares available for grants under the Equity Incentive Plan.

In addition to the establishment of the Equity Incentive Plan, in connection with the IPO, the Company entered into restricted stock unit (“RSU”) agreements with each of the executive officers and certain other key members of management. Pursuant to the RSU agreements, 1,197 stock-settled RSUs were granted, the aggregate value of which equals $25,000. The RSUs vested and settled in full upon the second anniversary of the IPO on November 2, 2019, resulting in the issuance of 1,159 shares, 419 of which were deposited into treasury in satisfaction of withholding tax obligations resulting from the vesting of the RSUs.

Option awards are granted at various times during the year, vest ratably at 25% per year, and are exercisable at the time of vesting. The options granted have a ten-year contractual term.
 
    A summary of the stock option activity as of December 31, 2019 is presented below:
(In thousands, except per share amounts)
Options
 
Weighted Average Exercise Price/Share
 
Weighted Average Remaining Contractual Term
 
Aggregate Intrinsic Value
Outstanding at September 30, 2019
8,619

 
$
8.15

 
6.3 years
 
$
80,826

Granted
5

 
18.82

 
 
 


Exercised
(430
)
 
5.22

 
 
 


Cancelled
(1
)
 
20.88

 
 
 
 
Forfeited
(32
)
 
16.52

 
 
 


Expired

 

 
 
 


Outstanding at December 31, 2019
8,161

 
$
8.28

 
6.0 years
 
$
89,300

Options exercisable at December 31, 2019
5,835

 
$
5.74

 
5.1 years
 
$
77,650

Options vested and expected to vest at December 31, 2019
8,142

 
$
8.27

 
6.0 years
 
$
89,196


The total intrinsic value of options exercised (which is the amount by which the stock price exceeded the exercise price of the options on the date of exercise) during the three months ended December 31, 2019 was $6,011.
    

32


A summary of the status of the Company's non-vested stock options as of and for the three months ended December 31, 2019 is presented below.
(In thousands, except per share amounts)
Shares
 
Weighted Average Grant Date Fair Value/Share
Nonvested at beginning of period
2,379

 
$
4.96

Granted
5

 
5.33

Vested
(25
)
 
2.27

Forfeited
(32
)
 
5.78

Nonvested at end of period
2,327

 
$
4.98


The total fair value of options vested during the three months ended December 31, 2019, was $57.

Restricted Stock Units
The following is a summary of the RSU activity for the three months ended December 31, 2019.
(In thousands, except per share amounts)
Shares
 
Weighted Average Grant Date Fair Value/Share
Outstanding at September 30, 2019
2,002

 
$
17.45

Granted
4

 
18.82

Vested
(1,159
)
 
20.88

Forfeited
(17
)
 
12.67

Outstanding at December 31, 2019
830

 
$
12.76

Vested and expected to vest at December 31, 2019
818

 
$
12.75

Expense Measurement and Recognition
Total share-based compensation expense was $3,691 and $4,559 during the three months ended December 31, 2019 and 2018, respectively, of which $3,680 and $4,525 was non-cash, respectively. The unrecognized compensation expense related to stock options and restricted stock units was $8,009 and $6,141, respectively at December 31, 2019, and is expected to be recognized over a weighted average period of 2.2 years and 2.1 years, respectively. The Company received $4,046 from the exercise of stock options during the three months ended December 31, 2019. The remaining stock options exercised during the three months ended December 31, 2019 were effected via a cashless net exercise.

Employee Stock Purchase Plan    
Effective October 1, 2018, the Company implemented an employee stock purchase plan (“ESPP”) which allows employees to purchase shares of the Company’s stock at 85% of the lower of the fair market value on the first day of the applicable offering period or on the last business day of a six-month purchase period within the offering period. These purchases were offered twice throughout fiscal 2019, and were paid by employees through payroll deductions over the respective six month purchase period, at which point the stock will be transferred to the employees. On December 21, 2018, the Company registered 11,297 shares of common stock, par value $0.01 per share, of which 5,000 are available for future issuance under the ESPP. During the three months ended December 31, 2019 and 2018, the Company incurred compensation expense of $39 and $155, respectively, in salaries and wages in respect of the ESPP, representing the fair value of the discounted price of the shares. These amounts are included in the total share-based compensation expense above. During the three months ended December 31, 2019, 56 shares were issued under the ESPP plan.

33


17. Concentration of Credit Risk
The Company’s cash and cash equivalents and accounts receivable are potentially subject to concentration of credit risk. Cash and cash equivalents are placed with financial institutions that management believes are of high credit quality. Accounts receivable are derived from revenue earned from customers located in the U.S. and internationally and generally do not require collateral. The Company’s trade receivables do not represent a significant concentration of credit risk at December 31, and September 30, 2019 due to the wide variety of customers and markets into which products are sold and their dispersion across geographic areas. The Company does perform ongoing credit evaluations of its customers and maintains an allowance for potential credit losses on trade receivables. As of and for the three months ended December 31, 2019 and 2018, no customer accounted for more than 10% of net sales or net accounts receivable.
The Company operates predominantly in ten countries worldwide and provides a wide range of proven product brands and advanced water and wastewater treatment technologies, mobile and emergency water supply solutions and service contract options through its Integrated Solutions and Services and Applied Product Technologies segments. The Company is a multi-national business but its sales and operations are primarily in the U.S. Sales to unaffiliated customers are based on the Company locations that maintain the customer relationship and transacts the external sale.
18. Related‑Party Transactions
The Company reimbursed AEA Investors LP (“AEA”), the Company’s private equity sponsor, for normal and customary expenses incurred by AEA on behalf of the Company. The Company notes that these related-party transactions have not been significant in the three months ended December 31, 2019 and 2018.
19. Leases
Lessee Accounting
As discussed in Note 2, “Summary of Significant Accounting Policies” the Company adopted ASU 2016-02 on October 1, 2019. ASU 2016-02 requires a lessee to recognize assets and liabilities on the balance sheet for all leases, with the result being the recognition of a right-of-use (“ROU”) asset and a corresponding lease liability. The lease liability is equal to the present value of the minimum lease payments for the term of the lease using the discount rate determined at lease commencement and including any optional renewal periods that were determined to be reasonably certain to be exercised. The ROU asset is equal to the initial measurement of the lease liability plus any lease payments made to the lessor at or before the commencement date and any unamortized initial indirect costs incurred by the lessee, less any unamortized lease incentives received. ROU assets are periodically reviewed for impairment whenever events or changes in circumstances arise. During the three months ended December 31, 2019, the Company incurred no impairment charges on ROU assets.
The discount rate utilized in calculating the lease liability is the rate implicit in the lease, if known, otherwise, the incremental borrowing rate (“IBR”) for the expected lease term is used. Generally, the Company cannot determine the interest rate implicit in the lease. The Company’s IBR approximates the rate the Company would have to pay on a collateralized basis to borrow an amount equal to the lease payments under similar terms.
The Company occupies certain facilities and operates certain equipment and vehicles under non‑cancelable lease arrangements. Lease agreements may contain lease escalation clauses and purchase and renewal options. At the inception of a contract, the Company determines whether the arrangement is or contains a lease. A lease is determined to exist if there is an identified asset, the Company has the right to obtain substantially all of the economic benefits from the use of the identified asset and the right to direct the use of the asset. Once a lease is determined to exist, the Company determines the lease classification at lease commencement. Leases are classified as operating or finance leases based on specific criteria. Operating lease expense is recognized on a straight-line basis on the Unaudited Consolidated Statements of Operations. Finance lease expense have front-loaded expense recognition that is recognized as depreciation expense and interest expense on the Unaudited Consolidated Statements of Operations. On the Consolidated Statements of Changes in Cash Flows, payments for operating leases are included in operating activities and payments for finance leases are included in financing activity, with the interest component included in operating activities.

34


The Company’s real estate leases often include options to extend the lease term; however, the Company has not included the renewal options in the ROU asset and lease liability because the likelihood of renewal was not reasonably certain. In addition, the Company has leases that include variable lease payments, for items such as maintenance or other operating expenses, which are expensed as incurred as variable lease expense.
Adoption of ASU 2016-02, Leases (Topic 842)
The Company applied Topic 842 to all existing leases at October 1, 2019 using the modified retrospective approach. As a result, prior period amounts have not been adjusted and continue to be reported in accordance with the Company’s historical accounting under Topic 840. The Company has elected the following package of practical expedients which exempts the Company from having to reassess: (i) whether expired or existing contracts contain a lease, (ii) the lease classification for expired or existing leases, and (iii) initial direct costs for existing leases. In addition, the Company elected to separate lease and non-lease components for all asset classes, did not elect to use hindsight to determine the lease term and made an accounting policy election for short-term leases which does not require the capitalization of leases with terms of 12 months or less.
As a result of adoption of Topic 842 on October 1, 2019, the Company recognized $42,073 of ROU assets related to operating leases in Operating lease right-of-use assets, net and $42,904 of corresponding lease liabilities, of which $13,596 is included in Accrued expenses and other liabilities and $29,308 is included in Obligation under operating leases on the Consolidated Balance Sheets. The difference is attributable to deferred rent balance as of September 30, 2019 that reduced the ROU asset balance on October 1, 2019, of which $73 was removed from Prepaid and other current assets and the remainder was recognized in Retained deficit on the Consolidated Balance Sheets. In addition, the Company recorded an ROU asset related to finance leases in Property, plant, and equipment, net of $2,126 and $3,245 in corresponding lease liabilities included in Other non‑current liabilities on the Consolidated Balance Sheets, with the difference recognized in Retained deficit. See Note 2, “Summary of Significant Accounting Policies” for further information on the impact of adoption.
The following represents the components of lease cost and other information for both operating and finance leases for the three months ended December 31, 2019:
Lease cost
 
Finance lease cost:
 
Amortization of ROU assets
$
3,420

Interest on lease liabilities
518

Operating lease cost
4,215

Short-term lease cost
837

Variable lease cost

Sublease income
(14
)
Total lease cost
$
8,976

 
 
Other information
 
Cash paid for amounts included in the measurement of lease liabilities
 
Operating cash flows from finance leases
$
520

Operating cash flows from operating leases
4,154

Financing cash flows from finance leases
3,346

ROU assets obtained in exchange for new finance lease liabilities
1,782

Weighted average remaining lease term - finance leases
3.9 years

Weighted average remaining lease term - operating leases
4.9 years

Weighted average discount rate - finance leases
5.00
%
Weighted average discount rate - operating leases
4.53
%

35


The following table reconciles future minimum undiscounted rental commitments for operating leases to operating lease liabilities record on the Consolidated Balance Sheet as of December 31, 2019:
Fiscal Year
 
Remainder of 2020
$
12,269

2021
13,304

2022
8,704

2023
6,266

2024
4,178

Thereafter
8,277

Total undiscounted lease payments
$
52,998

Present value adjustment
(5,952
)
Operating lease liabilities
47,046

Less current installments of obligations under operating leases
14,175

Obligations under operating leases, excluding current installments
$
32,871


The gross and net carrying values of the equipment under finance leases as of December 31, and September 30, 2019 was as follows:
 
 
Gross carrying amount
$
80,458

 
$
69,760

Net carrying amount
36,871

 
36,337

The following table reconciles future minimum undiscounted rental commitments for finance leases to the finance lease liabilities recorded on the Consolidated Balance Sheet as of December 31, 2019:
Fiscal Year
 
Remainder of 2020
$
10,643

2021
11,043

2022
8,416

2023
5,910

2024
3,716

Thereafter
2,443

Total undiscounted lease payments
42,171

Present value adjustment
(4,221
)
Finance lease liabilities
37,950

Less current installments of obligations under finance leases
12,006

Obligations under finance leases, excluding current installments
$
25,944

The current installments of obligations under finance leases are included in Accrued expenses and other liabilities. Obligations under finance leases, excluding current installments, are included in Other non-current liabilities.
Lessor Accounting
The Company is a lessor to multiple parties. The Company purchases equipment through internal funding or bank debt equal to the fair market value of the equipment. The equipment is then leased to customers for periods ranging from five to twenty years. These contracts generally contain both lease and non-lease components, including installation and maintenance services of the Company owned equipment. As part of the Company’s adoption of Topic 842, for contracts entered into after October 1, 2019, the Company elected the practical expedient to not separate lease and non-lease components when certain conditions are met, including the lease qualifying as an operating lease and the same revenue

36


recognition pattern for the lease and non-lease components. The Company accounts for these contacts with the customer as a combined component under the respective authoritative guidance for the predominant component in the contract, the lease or non-lease component. Lease income is included in Revenue from services on the Unaudited Consolidated Statements of Operations.
As of December 31, 2019, future minimum lease payments receivable under operating leases are as follows:
Fiscal year
 
Remainder of 2020
$
75,905

2021
51,107

2022
34,977

2023
24,564

2024
13,329

Thereafter
92,565

Future minimum lease payments
$
292,447

20. Commitments and Contingencies
Guarantees
From time to time, the Company is required to provide letters of credit, bank guarantees, or surety bonds in support of its commitments and as part of the terms and conditions on water treatment projects.  In addition, the Company is required to provide letters of credit or surety bonds to the Department of Environmental Protection or equivalent in some states in order to maintain its licenses to handle toxic substances at certain of its water treatment facilities.
These financial instruments typically expire after all Company commitments have been met, a period typically ranging from twelve months to ten years, or more in some circumstances.  The letters of credit, bank guarantees, or surety bonds are arranged through major banks or insurance companies. In the case of surety bonds, the Company generally indemnifies the issuer for all costs incurred if a claim is made against the bond. 
The following summarizes the Company’s outstanding letters of credit and surety bonds as of December 31, and September 30, 2019, respectively.
 
 
Revolving credit capacity
$
45,000

 
$
45,000

Letters of credit outstanding
13,088

 
12,956

Remaining revolving credit capacity
$
31,912

 
$
32,044

 
 
 
 
Surety capacity
$
230,000

 
$
220,000

Surety issuances
154,094

 
144,717

Remaining surety available
$
75,906

 
$
75,283


The longest maturity date of letters of credit and surety bonds in effect as of December 31, 2019 was March 26, 2029.
Litigation
From time to time, the Company is subject to various claims, charges and litigation matters that arise in the ordinary course of business. The Company believes these actions are a normal incident of the nature and kind of business in which the Company is engaged. While it is not feasible to predict the outcome of these matters with certainty, the Company does not believe that any asserted or unasserted legal claims or proceedings, individually or in the aggregate, will have a material adverse effect on its business, financial condition, results of operations or prospects.

37



21. Accrued Expenses and Other Liabilities
Accrued expenses and other liabilities consisted of the following:
 
 
Salaries, wages and other benefits
$
29,613

 
$
35,206

Obligation under operating leases
14,175

 

Obligation under finance leases
12,006

 
17,859

Third party commissions
10,296

 
11,394

Insurance liabilities
6,264

 
4,895

Taxes, other than income
4,137

 
5,215

Provisions for litigation
1,605

 
1,533

Option and Purchase Right
506

 

Severance payments
365

 
655

Earn-outs related to acquisitions
91

 
611

Other
22,598

 
24,471

 
$
101,656

 
$
101,839

22. Business Segments
The Company’s reportable operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated on a regular basis by the chief operating decision maker, or decision making group, in deciding how to allocate resources to an individual segment and in assessing performance. The key factors used to identify these reportable operating segments are the organization and alignment of the Company’s internal operations, the nature of the products and services, and customer type.
The Company has two reportable operating segments, Integrated Solutions and Services and Applied Product Technologies. The business segments are described as follows:
Integrated Solutions and Services is a group entirely focused on engaging directly with end users through direct sales with a market vertical focus. Integrated Solutions and Services provides tailored services and solutions in collaboration with the customers backed by life‑cycle services including on‑demand water, outsourced water, recycle / reuse and emergency response service alternatives to improve operational reliability, performance and environmental compliance. Key offerings within this segment also include equipment systems for industrial needs (influent water, boiler feed water, ultrahigh purity, process water, wastewater treatment and recycle / reuse), full-scale outsourcing of operations and maintenance, and municipal services, including odor and corrosion control services.
Applied Product Technologies is focused on developing product platforms to be sold primarily through third party channels. This segment primarily engages in indirect sales through independent sales representatives, distributors and aftermarket channels. Applied Product Technologies provides a range of highly differentiated and scalable products and technologies specified by global water treatment designers, OEMs, engineering firms and integrators. Key offerings within this segment include filtration and separation, disinfection, wastewater solutions, anode and electrochlorination technology and aquatics technologies and solutions for the global recreational and commercial pool market.
The Company evaluates its business segments’ operating results based on earnings before interest, taxes, depreciation and amortization, and certain other charges that are specific to the activities of the respective segments. Corporate activities include general corporate expenses, elimination of intersegment transactions, interest income and expense and certain other charges. Certain other charges include restructuring and other business transformation charges that have been undertaken to align and reposition the Company to the current reporting structure, acquisition related costs (including

38


transaction costs, certain integration costs and recognition of backlog intangible assets recorded in purchase accounting) and share-based compensation charges. 
Since certain administrative and other operating expenses and other items have not been allocated to business segments, the results in the below table are not necessarily a measure computed in accordance with generally accepted accounting principles and may not be comparable to other companies.
 
Three Months Ended
December 31,
 
2019
 
2018
Total sales
 
 
 
Integrated Solutions and Services
$
231,800

 
$
212,277

Applied Product Technologies
138,529

 
130,534

Total sales
370,329

 
342,811

Intersegment sales
 
 
 
Integrated Solutions and Services
3,662

 
1,779

Applied Product Technologies
20,562

 
18,030

Total intersegment sales
24,224

 
19,809

Sales to external customers
 
 
 
Integrated Solutions and Services
228,138

 
210,498

Applied Product Technologies
117,967

 
112,504

Total sales
346,105

 
323,002

Earnings before interest, taxes, depreciation and amortization (EBITDA)
 
 
 
Integrated Solutions and Services
48,775

 
41,884

Applied Product Technologies
66,716

 
8,851

Corporate
(20,656
)
 
(34,004
)
Total EBITDA
94,835

 
16,731

Depreciation and amortization
 
 
 
Integrated Solutions and Services
15,621

 
13,958

Applied Product Technologies
3,574

 
4,334

Corporate
5,948

 
4,798

Total depreciation and amortization
25,143

 
23,090

Operating profit (loss)
 
 
 
Integrated Solutions and Services
33,154

 
27,926

Applied Product Technologies
63,142

 
4,517

Corporate
(26,604
)
 
(38,802
)
Total operating profit
69,692

 
(6,359
)
Interest expense
(13,583
)
 
(14,443
)
Income (loss) before income taxes
56,109

 
(20,802
)
Income tax (expense) benefit
(2,603
)
 
4,514

Net income (loss)
$
53,506

 
$
(16,288
)
Capital expenditures
 
 
 
Integrated Solutions and Services
$
14,187

 
$
13,685

Applied Product Technologies
2,283

 
2,208

Corporate
1,102

 
1,676

Total capital expenditures
$
17,572

 
$
17,569


39


 
 
Assets
 
 
 
Integrated Solutions and Services
$
818,051

 
$
762,707

Applied Product Technologies
596,003

 
657,879

Corporate
396,248

 
317,262

Total assets
$
1,810,302

 
$
1,737,848

Goodwill
 
 
 
Integrated Solutions and Services
$
224,279

 
$
222,013

Applied Product Technologies
172,727

 
170,877

Total goodwill
$
397,006

 
$
392,890

23. Earnings Per Share
The following table sets forth the computation of basic and diluted earnings (loss) from continuing operations per common share (in thousands, except per share amounts):
 
Three Months Ended
December 31,
 
2019
 
2018
Numerator:
 
 
 
Numerator for basic and diluted earnings (loss) per common share—Net income (loss) attributable to Evoqua Water Technologies Corp.
$
53,145

 
$
(16,730
)
Denominator:
 
 
 
Denominator for basic net income (loss) per common share—weighted average shares
115,586

 
113,950

Effect of dilutive securities:
 
 
 
Share‑based compensation
5,443

 

Denominator for diluted net income (loss) per common share—adjusted weighted average shares
121,029

 
113,950

Basic earnings (loss) attributable to Evoqua Water Technologies Corp. per common share
$
0.46

 
$
(0.15
)
Diluted earnings (loss) attributable to Evoqua Water Technologies Corp. per common share
$
0.44

 
$
(0.15
)
Since the Company was in a net loss position for the three months ended December 31, 2018, there was no difference between the number of shares used to calculate basic and diluted loss per share. Because of their anti-dilutive effect, 4,168 common share equivalents, comprised of employee stock options, have been excluded from the diluted EPS calculation for the three months ended December 31, 2018.

40


24. Subsequent Events
In January 2020, the Company utilized $100 million of the proceeds from the sale of the Memcor product line to repay a portion of the Company’s First Lien Term Loans. As a result of this payment, the Company moved $100 million from Long-term debt, net of deferred financing fees to Current portion of debt.
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis of our financial condition and results of our operations should be read in conjunction with the Unaudited Consolidated Financial Statements, including the notes, included in Item 1 of this Quarterly Report on Form 10-Q (this “Report”), and with our audited consolidated financial statements and the related notes thereto in our Annual Report on Form 10-K for the fiscal year ended September 30, 2019, as filed with the SEC on November 25, 2019 (the “2019 Annual Report”). You should review the disclosures under the heading “Item 1A. Risk Factors” in the 2019 Annual Report, as well as any cautionary language in this report, for a discussion of important factors that could cause actual results to differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis. Unless otherwise indicated or the context otherwise requires, all references to the Company,” “Evoqua,” “Evoqua Water Technologies Corp.,” “EWT Holdings I Corp.,” “we,” “us,” “our” and similar terms refer to Evoqua Water Technologies Corp., together with its consolidated subsidiaries. Unless otherwise specified, all dollar amounts in this section are referred to in millions.
Overview and Background
We are a leading provider of mission critical water and wastewater treatment solutions, offering a broad portfolio of products, services and expertise to support industrial, municipal and recreational customers who value water. With over 200,000 installations worldwide, we hold leading positions in the industrial, commercial and municipal water treatment markets in North America. We offer a comprehensive portfolio of differentiated, proprietary technology solutions sold under a number of market‑leading and well‑established brands to our global customer base. We have worked to protect water, the environment and our employees for over 100 years. As a result, we have earned a reputation for quality, safety and reliability and are sought out by our customers to solve the full range of their water treatment needs, and maintaining our reputation is critical to the success of our business.
Our solutions are designed to ensure that our customers have the quantity and quality of water that meets their unique specifications. We enable our customers to achieve lower costs through greater uptime, throughput and efficiency in their operations and support their regulatory compliance and environmental sustainability. We deliver and maintain these mission critical solutions through the largest service network in North America, assuring our customers continuous uptime with 97 branches as of December 31, 2019. We have an extensive service and support network, and as a result, a certified Evoqua Service Technician is generally no more than a two‑hour drive from more than 90% of our North American customers’ sites.
Our vision “to be the world’s first choice for water solutions” and our values of “integrity, customers, performance and sustainable” foster a corporate culture that is focused on establishing a workforce that is enabled, empowered and accountable, which creates a highly entrepreneurial and dynamic work environment. Our purpose is “Transforming water. Enriching life.” We draw from a long legacy of water treatment innovations and industry firsts, supported by more than 1,100 granted or pending patents, which in aggregate are imperative to our business. Our core technologies are primarily focused on removing impurities from water, rather than neutralizing them through the addition of chemicals, and we are able to achieve purification levels which are 1,000 times greater than typical drinking water.
Business Segments
Our business is organized by customer base and offerings into two reportable operating segments that each draw from the same reservoir of leading technologies, shared manufacturing infrastructure, common business processes and corporate philosophies. Our reportable operating segments consist of: (i) our Integrated Solutions and Services segment

41


and (ii) our Applied Product Technologies segment. The key factors used to identify these reportable operating segments are the organization and alignment of our internal operations, the nature of the products and services and customer type.
Within the Integrated Solutions and Services segment, we primarily provide tailored solutions in collaboration with our customers backed by life‑cycle services including on‑demand water, outsourced water, recycle and reuse and emergency response service alternatives to improve operational reliability, performance and environmental compliance.
Within the Applied Product Technologies segment, we provide a highly differentiated and scalable range of products and technologies specified by global water treatment designers, OEMs, engineering firms and integrators.
We evaluate our business segments’ operating results based on income from operations and EBITDA or Adjusted EBITDA on a segment basis. Corporate activities include general corporate expenses, elimination of intersegment transactions, interest income and expense and certain other charges, which have not been allocated to business segments. As such, the segment results provided herein may not be comparable to other companies.
Organic Growth Drivers
Market Growth
We maintain a leading position among customers in growing industries that utilize water as a critical part of their operations or production processes, including pharmaceuticals and health sciences, microelectronics, food and beverage, hydrocarbon and chemical processing, power, general manufacturing, municipal drinking and wastewater, marine and aquatics. Water treatment is an essential, non‑discretionary market that is growing in importance as access to clean water has become an international priority. Underpinning this growth are a number of global, long‑term trends that have resulted in increasingly stringent effluent regulations, along with a growing demand for cleaner and sustainable waste streams for reuse. These trends include the growing global population, increasing levels of urbanization and continued global economic growth, and we have seen these trends manifest themselves within our various end markets creating multiple avenues of growth. For example, within the industrial market, water is an integral and meaningful component in the production of a wide‑range of goods spanning from consumer electronics to automobiles.
Our Existing Customer Base
We believe our strong brands, leading position in highly fragmented markets, scalable and global offerings, leading installed base and unique ability to provide complete treatment solutions will enable us to capture a larger share of our existing customers’ water treatment spend while expanding with existing and new customers into adjacent end‑markets and underpenetrated regions, including by investing in our sales force and cross‑selling to existing customers. We believe that we are uniquely positioned to further penetrate our core markets, with over 200,000 installations across over 38,000 global customers. We maintain a customer‑intimate business model with strong brand value and provide solutions‑focused offerings capable of serving a customer’s full lifecycle water treatment needs, both in current and new geographic regions.
Our Service Model
We selectively target high value projects with opportunities for recurring business through service, parts and other aftermarket opportunities over the lifecycle of the process or capital equipment. In particular, we have developed internet‑connected monitoring technologies through the deployment of our WaterOne® service platform, which enables customers to outsource their water treatment systems and focus on their core business, offering customers system optimization, predictive and proactive service, and simplified billing and pricing. Our WaterOne® platform also enables us to transition our customers to pricing models based on usage, which otherwise would not have been possible without technological advancement. Our technology solutions provide customers with increased stability and predictability in water‑related costs, while enabling us to optimize our service route network and on demand offerings through predictive analytics, which we believe will result in market share gains, improved service levels, increased barriers to entry and reduced costs.

42


Product and Technology Development
We develop our technologies through in‑house research, development and engineering and targeted tuck‑in, vertical market and geography‑expanding, technology-enhancing acquisitions. We have a reservoir of recently launched technologies and a strong pipeline of new offerings designed to provide customers with innovative, value‑enhancing solutions. Furthermore, since April 2016, we have successfully completed thirteen acquisitions and the acquisition of a 60% interest in Frontier Water Systems LLC, each of which expands our vertical markets and geographic reach and enhance our technologies, strengthening our existing capabilities and adding new capabilities and cross selling opportunities in areas such as mobile wastewater treatment, soil and air treatment, regenerative media filtration, anodes, UV and ozone disinfection, aerobic and anaerobic biological treatment technologies and electrochemical and electrochlorination cells. We are able to rapidly scale new technologies using our leading direct and third‑party sales channels and our relationships with key influencers, including municipal representatives, engineering firms, designers and other system specifiers. We believe our continued investment in driving penetration of our recently launched technologies, robust pipeline of new capabilities and best‑in‑class channels to market will allow us to continue to address our customer needs across the water lifecycle.
Operational Excellence
We believe that continuous improvement of our operations, processes and organizational structure is a key driver of our earnings growth. We have separately identified and are pursuing a number of discrete initiatives which, if successful, we expect could result in additional cost savings over the next two years. These initiatives include our supply chain improvement program to consolidate and manage global spending, our improved logistics and transportation management program, capturing benefits of our WaterOne® platform and further optimizing our engineering cost structure, our global shared services organization and our sales, inventory and operations planning. These improvements focus on creating value for customers through reduced lead times, improved quality and superior customer support, while also creating value for shareholders through enhanced earnings growth. Furthermore, as a result of significant investments we have made in our footprint and facilities, we believe we have capacity to support our planned growth without commensurate increase in fixed costs.
Acquisitions and Divestitures
We believe that capex-like, tuck‑in acquisitions present a key opportunity within our overall growth strategy, which we will continue to evaluate strategically. These strategic acquisitions are expected to enable us to accelerate our growth by extending our critical mass in existing markets, as well as expand in new geographies and new end market verticals. Our existing customer relationships, best‑in‑class channels to market and ability to rapidly commercialize technologies provide a strong platform to drive rapid growth in the businesses we acquire. To capitalize on these opportunities, we have built an experienced team dedicated to mergers and acquisitions that has, since April 2016, successfully completed thirteen acquisitions and the acquisition of a 60% interest in Frontier Water Systems LLC, each of which expands our vertical markets and geographic reach and enhance our technologies, with purchase prices ranging from approximately $2.0 million to approximately $283.7 million, and pre‑acquisition revenues ranging from approximately $3.1 million to approximately $55.7 million.
On December 31, 2019 we completed the sale of the Memcor product line to DuPont de Nemours, Inc. (DuPont). The aggregate purchase price paid by DuPont was $110.0 million in cash, subject to certain adjustments. Following adjustments for cash and net working capital, gross proceeds paid by DuPont were $121.3 million. The Company recognized a $49.0 million net pre-tax benefit on sale of the Memcor product line, which is net of $8.3 million of discretionary compensation payments to employees in connection with the transaction and $1.0 million in transaction costs incurred in the three months ended December 31, 2019. The Company and DuPont have a history of collaboration, and following the sale, DuPont will continue to supply the Company with Memcor® products.
Key Factors and Trends Affecting Our Business and Financial Statements
Various trends and other factors affect or have affected our operating results, including:

43


Overall economic trends. The overall economic environment and related changes in industrial, commercial and municipal spending impact our business. In general, positive conditions in the broader economy promote industrial, commercial and municipal customer spending, while economic weakness results in a reduction of new industrial, commercial and municipal project activity. Macroeconomic factors that can affect customer spending patterns, and thereby our results of operations, include population growth, total water consumption, municipal budgets, employment rates, business conditions, the availability of credit or capital, interest rates, tax rates, imposition of tariffs and regulatory changes. Since the businesses of our customers vary in cyclicality, periodic downturns in any specific sector typically have modest impacts on our overall business.
Changes in costs and availability. We have significant exposures to certain commodities, including steel, caustic, carbon, calcium nitrate and iridium, and volatility in the market price and availability of these commodity input materials has a direct impact on our costs and our business. For example, the U.S. government and other governments have recently imposed greater restrictions on international trade, including tariffs and/or other trade restraints on certain materials. These restrictions, particularly those related to China, have increases and could further increase the cost of our products and have restricted and could further restrict availability of certain commodities, which may result in delays in our execution of projects. Although we have offset a portion of these cost increases through price increases, there can be no assurance that we will be able to continue to recuperate additional cost increases from our customers through product price increases. If we are unable to manage commodity fluctuations through pricing actions, cost savings projects and sourcing decisions as well as through consistent productivity improvements, it may adversely impact our gross profit and gross margin. Further, additional potential acquisitions and international expansion will place increased demands on our operational, managerial, administrative and other resources. Managing our growth effectively will require us to continue to enhance our management systems, financial and management controls and information systems. We will also be required to hire, train and retain operational and sales personnel, which affects our operating margins.
Inflation and deflation trends. Our financial results can be expected to be directly impacted by substantial increases in costs due to commodity cost increases or general inflation which could lead to a reduction in our revenues as well as greater margin pressure as increased costs may not be able to be passed on to customers.
Fluctuation in quarterly results. Our quarterly results have historically varied depending upon a variety of factors, including funding, readiness of projects, regulatory approvals and significant weather events. In addition, our contracts for large capital water treatment projects, systems and solutions for industrial, commercial and municipal applications are generally fixed‑price contracts with milestone billings. As a result of these factors, our working capital requirements and demands on our distribution and delivery network may fluctuate during the year.
New products and technologies. Our ability to maintain our appeal to existing customers and attract new customers depends on our ability to originate, develop and offer a compelling array of products, services and solutions responsive to evolving customer innovations, preferences and specifications. We expect that increased use of water in industrial and commercial processes will drive increased customer demand in the future, and our ability to grow will depend in part on effectively responding to innovation in our customers’ processes and systems. Further, our ability to provide products that comply with evolving government regulations will also be a driver of the appeal of our products, services and solutions to industrial and commercial customers.
Government policies. Decaying water systems in the United States (“U.S.”) will require critical drinking water and wastewater repairs, often led by municipal governments. Further, as U.S. states increase regulation on existing and emerging contaminants, we expect that our customers will increasingly require sustainable solutions to their water‑related needs. In general, increased infrastructure investment and more stringent municipal, state and federal regulations promote increased spending on our products, services and solutions, while a slowdown in investment in public infrastructure or the elimination of key environmental regulations could result in lower industrial and municipal spending on water systems and products.
Availability of water. In general, we expect demand for our products and services to increase as the availability of clean water from public sources decreases. Secular trends that will drive demand for water across a multitude of industrial, commercial and municipal applications include global population growth, urbanization, industrialization and overall economic growth. In addition, the supply of clean water could be adversely impacted by factors including an aging water infrastructure within North America and increased levels of water stress from seasonal rainfall, inadequate water storage options or treatment technologies. Because water is a critical component and byproduct of many processes, including in

44


manufacturing and product development, we expect that, as global consumption patterns evolve and water shortages persist, demand for our equipment and services will continue to increase.
Operational investment. Our historical operating results reflect the impact of our ongoing investments to support our growth. We have made significant investments in our business that we believe have laid the foundation for continued profitable growth. Activities related to operational investments include employee training and development, integrating acquired businesses, implementing enhanced information systems, research, development and engineering investments and other activities to enable us to support our operating model.
Our ability to source and distribute products effectively. Our revenues are affected by our ability to purchase our inputs in sufficient quantities at competitive prices. While we believe our suppliers have adequate capacity to meet our current and anticipated demand, our level of revenues could be adversely affected in the event of constraints in our supply chain, including the inability of our suppliers to produce sufficient quantities of raw materials in a manner that is able to match demand from our customers.
Contractual relationships with customers. Due to our large installed base and the nature of our contractual relationships with our customers, we have high visibility into a large portion of our revenue. The one‑ to twenty‑year terms of many of our service contracts and the regular delivery and replacement of many of our products help to insulate us from the negative impact of any economic decline.
Exchange rates. The reporting currency for our Unaudited Consolidated Financial Statements is the U.S. dollar. We operate in numerous countries around the world and therefore, certain of our assets, liabilities, revenues and expenses are denominated in functional currencies other than the U.S. dollar, primarily in the euro, U.K. sterling, Chinese renminbi, Canadian dollar, Australian dollar and Singapore dollar. To prepare our Unaudited Consolidated Financial Statements we must translate those assets, liabilities, revenues and expenses into U.S. dollars at the applicable exchange rate. As a result, increases or decreases in the value of the U.S. dollar against these other currencies will affect the amount of these items recorded in our Unaudited Consolidated Financial Statements, even if their value has not changed in the functional currency. While we believe that we are not susceptible to any material impact on our results of operations caused by fluctuations in exchange rates because our operations are primarily conducted in the U.S., if we expand our foreign operations in the future, substantial increases or decreases in the value of the U.S. dollar relative to these other currencies could have a significant impact on our results of operations.
How We Assess the Performance of Our Business
In assessing the performance of our business, we consider a variety of performance and financial measures. The key indicators of the financial condition and operating performance of our business are revenue, gross profit, gross margin, operating expenses, net income (loss) and Adjusted EBITDA.
Revenue
Our sales are a function of sales volumes and selling prices, each of which is a function of the mix of product and service sales, and consist primarily of:
sales of tailored light industry technologies, heavy industry technologies and environmental products, services and solutions in collaboration with our industrial customers, backed by lifecycle services including emergency response services and outsourced water alternatives, to a broad group of industrial customers in our U.S., Canada and Singapore markets;
sales of products, services and solutions to engineering firms and municipalities to purify drinking water and treat wastewater globally; and
sales of a wide variety of differentiated products and technologies, to an array of OEM, distributor, end‑user, engineering firm and integrator customers in all of our geographic markets and aftermarket channels.
Cost of Sales, Gross Profit and Gross Margin
Gross profit is determined by subtracting cost of product sales and cost of services from our product and services revenue. Gross margin measures gross profit as a percentage of our combined product and services revenue.

45


Cost of product sales consists of all manufacturing costs required to bring a product to a ready for sale condition, including direct and indirect materials, direct and indirect labor costs including benefits, freight, depreciation, information technology, rental and insurance, repair and maintenance, utilities, other manufacturing costs, warranties and third party commissions.
Cost of services primarily consists of the cost of personnel and travel for our field service, supply chain and technicians, depreciation of equipment and field service vehicles and freight costs.
Operating Expenses
Operating expenses consist primarily of general and administrative, sales and marketing and research and development expenses.
General and Administrative. General and administrative expenses (“G&A expense”) consist of fixed overhead personnel expenses associated with our corporate functions and our service organization (including district and branch managers, customer service, contract renewals and regeneration plant management). We expect our general and administrative expenses to increase due to the anticipated growth of our business and related infrastructure as well as due to the legal, accounting, insurance, investor relations and other costs associated with being a public company.
Sales and Marketing. Sales and marketing expenses (“S&M expense”) consist primarily of advertising and marketing promotions of our products, services and solutions and related personnel expenses (including all Evoqua sales and application employees’ base compensation and incentives), as well as sponsorship costs, consulting and contractor expenses, travel, display expenses and related amortization. We expect our sales and marketing expenses to increase as we continue to actively promote our products, services and solutions.
Research and Development. Research and development expenses (“R&D expense”) consist primarily of personnel expenses related to research and development, patents, sustaining engineering, consulting and contractor expenses, tooling and prototype materials and overhead costs allocated to such expenses. Substantially all of our research and development expenses are related to developing new products and services and improving our existing products and services. To date, research and development expenses have been expensed as incurred, because the period between achieving technological feasibility and the release of products and services for sale has been short and development costs qualifying for capitalization have been insignificant.
R&D expense can fluctuate depending on our determination to invest in developing new products, services and solutions and enhancing our existing products, services and solutions versus adding these capabilities through a mergers and acquisitions strategy.
Net Income (Loss)
Net income (loss) is determined by subtracting operating expenses and interest expense from, and adding other operating income (expense), equity income from our partnership interest in Treated Water Outsourcing and income tax benefit (expense) to, gross profit. For more information on how we determine gross profit, see “Gross Profit.”
Adjusted EBITDA
Adjusted EBITDA is one of the primary metrics used by management to evaluate the financial performance of our business. Adjusted EBITDA is defined as net income (loss) before interest expense, income tax benefit (expense) and depreciation and amortization, adjusted for the impact of certain other items, including restructuring and related business transformation costs, purchase accounting adjustment costs, non-cash share-based compensation, sponsor fees, transaction costs and other gains, losses and expenses. We present Adjusted EBITDA, which is not a recognized financial measure under GAAP, because we believe it is frequently used by analysts, investors and other interested parties to evaluate companies in our industry. Further, we believe it is helpful in highlighting trends in our operating results and provides greater clarity to management and our investors regarding the operational impact of long term strategic decisions regarding capital structure, the tax jurisdictions in which we operate and capital investments. Management uses Adjusted EBITDA to supplement GAAP measures of performance as follows:
to assist investors and analysts in comparing our operating performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance;

46


in our management incentive compensation which is based in part on components of Adjusted EBITDA;
in certain calculations under our senior secured credit facilities, which use components of Adjusted EBITDA;
to evaluate the effectiveness of our business strategies;
to make budgeting decisions; and
to compare our performance against that of other peer companies using similar measures.
In addition to the above, our chief operating decision maker uses EBITDA and Adjusted EBITDA of each reportable operating segment to evaluate the operating performance of such segments. EBITDA and Adjusted EBITDA of the reportable operating segments does not include certain charges that are presented within Corporate activities. These charges include certain restructuring and other business transformation charges that have been incurred to align and reposition the Company to the current reporting structure, acquisition related costs (including transaction costs, integration costs and recognition of backlog intangible assets recorded in purchase accounting) and share-based compensation charges.
You are encouraged to evaluate each adjustment and the reasons we consider it appropriate for supplemental analysis. In addition, in evaluating Adjusted EBITDA, you should be aware that in the future, we may incur expenses similar to the adjustments in the presentation of Adjusted EBITDA. Our presentation of Adjusted EBITDA should not be construed as an inference that our future results will be unaffected by unusual or non‑recurring items. In addition, Adjusted EBITDA may not be comparable to similarly titled measures used by other companies in our industry or across different industries.
The following is a reconciliation of our Net income (loss) to Adjusted EBITDA (unaudited, amounts in millions):
 
Three Months Ended
December 31,
 
2019
 
2018
Net income (loss)
$
53.5

 
$
(16.3
)
Income tax expense (benefit)
2.6

 
(4.5
)
Interest expense
13.6

 
14.4

Operating profit (loss)
69.7

 
(6.4
)
Depreciation and amortization
25.1

 
23.1

EBITDA
94.8

 
16.7

Restructuring and related business transformation costs (a)
1.7

 
5.7

Share-based compensation (b)
3.7

 
4.6

Transaction costs (c)
0.2

 
2.1

Other (gains) losses and expenses (d)
(56.8
)
 
9.3

Adjusted EBITDA
$
43.6

 
$
38.4

(a)    Restructuring and related business transformation costs
Adjusted EBITDA is calculated prior to considering certain restructuring or business transformation events. These events may occur over extended periods of time, and in some cases it is reasonably possible that they could reoccur in future periods based on reorganizations of the business, cost reduction or productivity improvement needs, or in response to economic conditions. For the periods presented such events include the following:
(i)
Certain costs and expenses in connection with various restructuring initiatives, including severance costs, relocation costs, recruiting expenses, and third-party consultant costs to assist with these initiatives. This includes:
(A) 
amounts related to the Company’s transition from a three-segment structure to a two-segment operating model designed to better serve the needs of customers worldwide; and

47


(B)
amounts related to various other initiatives implemented to restructure and reorganize our business with the appropriate management team and cost structure.
 
Three Months Ended
December 31,
 
2019
 
2018
Two-segment restructuring(1)
$
1.0

 
$
1.9

Cost of sales
0.3

 
0.2

S&M expense

 
0.2

G&A expense
0.3

 
1.5

Other operating (income) expense
0.4

 

Various other initiatives(2)
$
0.2

 
$
0.5

Cost of product sales and services ("Cost of sales")
0.1

 
0.3

G&A expense
0.1

 
0.2

Total
$
1.2

 
$
2.4

(1) 
of which $0.7 million and $1.9 million is reflected in restructuring charges in Note 13, “Restructuring and Related Charges” in Part I, Item 1 of this Quarterly Report on Form 10-Q (the “Restructuring Footnote”) in the three months ended December 31, 2019 and 2018, respectively.
(2) 
all of which is reflected in the Restructuring Footnote in the three months ended December 31, 2019 and 2018, respectively.
(ii)
legal settlement costs and intellectual property related fees associated with legacy matters prior to the AEA Acquisition, including fees and settlement costs related to product warranty litigation on MEMCOR® products and certain discontinued products. This includes:
 
Three Months Ended
December 31,
 
2019
 
2018
Cost of sales
$
0.1

 
$
0.1

G&A expense

 
0.3

Total
$
0.1

 
$
0.4

(iii)
expenses associated with our information technology and functional infrastructure transformation subsequent to the AEA Acquisition, including activities to optimize information technology systems and functional infrastructure processes. This includes:
 
Three Months Ended
December 31,
 
2019
 
2018
Cost of sales
$
0.1

 
$
0.1

G&A expense
0.3

 
2.7

Total
$
0.4

 
$
2.8

(iv)
costs associated with our IPO and secondary offering as well as costs incurred by us in connection with establishment of our public company compliance structure and processes, including consultant costs. This includes:

48


 
Three Months Ended
December 31,
 
2019
 
2018
G&A expense
$

 
$
0.1

Total
$

 
$
0.1

(b)
Share-based compensation
Adjusted EBITDA is calculated prior to considering non‑cash share‑based compensation expenses related to equity awards. See Note 16, “Share-Based Compensation” in Part I, Item 1 of this Quarterly Report on Form 10-Q for further detail.
(c)
Transaction related costs    
Adjusted EBITDA is calculated prior to considering transaction, integration and restructuring costs associated with business combinations because these costs are unique to each transaction and represent costs that were incurred as a result of the transaction decision. Such costs may include, without limitation, consulting and legal costs associated with due diligence and closing a transaction, restructuring and integration costs such as severance, facility consolidation costs, product rationalization or inventory obsolescence charges, system integration or conversion costs, fair value changes associated with contingent consideration, and costs associated with any litigation matters that arise subsequent to our acquisition of a business for which the matter in question preceded the transaction, but was not known, not probable or unresolved at the date of acquisition. We believe that viewing earnings prior to considering these charges provides investors with useful additional perspective because the significant costs incurred in connection with business combinations result primarily from the need to eliminate duplicate assets, activities or employees - a natural result of acquiring or disposing a fully integrated set of activities. Integration and restructuring costs associated with a business combination may occur over several years. This includes:
 
Three Months Ended
December 31,
 
2019
 
2018
Cost of sales
$
0.1

 
$
0.2

G&A expense
0.4

 
1.9

Other operating (income) expense
(0.3
)
 

Total
$
0.2

 
$
2.1

(d)
Other (gains), losses and expenses
Adjusted EBITDA is calculated prior to considering certain other significant (gains), losses and expenses. Such significant items represent substantive and/or unusual items that are evaluated on an individual basis. Such evaluation considers both the quantitative and qualitative aspects of their nature and they may be highly variable and difficult to predict. Unusual items may represent items that are not part of our ongoing business, items that, either as a result of their nature or size, we would not expect to occur as part of our normal business on a regular basis, items that would be non-recurring, or items related to products we no longer sell. While not all-inclusive, examples of items that could be included as other (gains), losses and expenses would be amounts related to non-cash foreign currency exchange gains and losses on intercompany loans, significant warranty events, and certain disposals of businesses, products or facilities that do not qualify as discontinued operations under GAAP. For the periods presented such events include the following:
(i)
impact of foreign exchange gains and losses;
(ii)
foreign exchange impact related to headquarter allocations;
(iii)
expenses on disposal related to maintaining non‑operational business locations, net of gain on sale;

49


(iv)
expenses incurred by the Company related to the remediation of manufacturing defects caused by a third- party vendor for which the Company is seeking restitution;
(v)
charges incurred by the Company related to product rationalization in its electro-chlorination business; and
(vi)
net pre-tax benefit on the sale of the Memcor product line, which is net of $8.3 million of discretionary compensation payments to employees in connection with the transaction and $1.0 million in transaction costs incurred in the three months ended December 31, 2019.
Other adjustments include the following (gains), losses and expenses for the periods presented below:
Three Months Ended December 31, 2019
 
Other Adjustments
 
(i)
 
(ii)
 
(iii)
 
(iv)
 
(v)
 
(vi)
 
Total
Cost of sales
$
(0.4
)
 
$

 
$

 
$
0.2

 
$
0.1

 
$
0.1

 
$

G&A expense
(6.2
)
 
0.1

 

 

 

 
0.9

 
(5.2
)
Other operating (income) expense

 

 

 
(1.6
)
 

 
(50.0
)
 
(51.6
)
Total
$
(6.6
)
 
$
0.1

 
$

 
$
(1.4
)
 
$
0.1

 
$
(49.0
)
 
$
(56.8
)
Three Months Ended December 31, 2018
 
Other Adjustments
 
(i)
 
(ii)
 
(iii)
 
(iv)
 
(v)
 
(vi)
 
Total
Cost of sales
$
0.2

 
$

 
$
1.0

 
$

 
$
3.1

 
$

 
$
4.3

G&A expense
4.5

 
0.5

 

 

 

 

 
5.0

Total
$
4.7

 
$
0.5

 
$
1.0

 
$

 
$
3.1

 
$

 
$
9.3


50


Results of Operations
The following tables summarize key components of our results of operations for the periods indicated:
 
Three Months Ended December 31,
 
2019
 
2018
 
 
(In millions, except per share amounts)
 
 
% of Revenue
 
 
 
% of Revenue
 
% Variance
Revenue
$
346.1

 
100.0
 %
 
$
323.0

 
100.0
 %
 
7.2
 %
Cost of product sales and services
(240.4
)
 
(69.5
)%
 
(234.3
)
 
(72.5
)%
 
2.6
 %
Gross profit
105.7

 
30.5
 %
 
88.7

 
27.5
 %
 
19.2
 %
General and administrative expense
(45.8
)
 
(13.2
)%
 
(54.8
)
 
(17.0
)%
 
(16.4
)%
Sales and marketing expense
(38.0
)
 
(11.0
)%
 
(36.2
)
 
(11.2
)%
 
5.0
 %
Research and development expense
(3.7
)
 
(1.1
)%
 
(4.1
)
 
(1.3
)%
 
(9.8
)%
Other operating income (expense), net
51.5

 
14.9
 %
 

 
 %
 
100.0
 %
Interest expense
(13.6
)
 
(3.9
)%
 
(14.4
)
 
(4.5
)%
 
(5.6
)%
Income (loss) before income taxes
56.1

 
16.2
 %
 
(20.8
)
 
(6.4
)%
 
(369.7
)%
Income tax (expense) benefit
(2.6
)
 
(0.8
)%
 
4.5

 
1.4
 %
 
(157.8
)%
Net income (loss)
53.5

 
15.5
 %
 
(16.3
)
 
(5.0
)%
 
(428.2
)%
Net income attributable to non‑controlling interest
0.4

 
0.1
 %
 
0.4

 
0.1
 %
 
 %
Net income (loss) attributable to Evoqua Water Technologies Corp.
$
53.1

 
15.3
 %
 
$
(16.7
)
 
(5.2
)%
 
(418.0
)%
 
 
 
 
 
 
 
 
 
 
Weighted average shares outstanding
 
 
 
 
 
 
 
 
 
Basic
115.6

 
 
 
114.0

 
 
 
 
Diluted
121.0

 
 
 
114.0

 
 
 
 
Earnings (loss) per share
 
 
 
 
 
 
 
 
 
Basic
$
0.46

 
 
 
$
(0.15
)
 
 
 
 
Diluted
$
0.44

 
 
 
$
(0.15
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Other financial data:
 
 
 
 
 
 
 
 
 
Adjusted EBITDA(1)
$
43.6

 
12.6
 %
 
$
38.4

 
11.9
 %
 
13.5
 %

(1)
For the definition of Adjusted EBITDA and a reconciliation to net income (loss), its most directly comparable financial measure presented in accordance with GAAP, see “How We Assess the Performance of Our Business-Adjusted EBITDA.”
Consolidated Results
Revenues-Revenues increased $23.1 million, or 7.2%, to $346.1 million in the three months ended December 31, 2019 from $323.0 million in the three months ended December 31, 2018.
The following table provides the change in revenues from product sales and revenues from services, respectively:
 
Three Months Ended December 31,
 
2019
 
2018
 
% Variance
 
 
 
% of
Revenue
 
 
 
% of
Revenue
 
 
Revenue from product sales
$
196.6

 
56.8
%
 
$
180.1

 
55.8
%
 
9.2
%
Revenue from services
149.5

 
43.2
%
 
142.9

 
44.2
%
 
4.6
%
 
$
346.1

 
100.0
%
 
$
323.0

 
100.0
%
 
7.2
%
Revenues from product sales increased $16.5 million, or 9.2%, to $196.6 million in the three months ended December 31, 2019 from $180.1 million in the three months ended December 31, 2018. The increase was primarily driven by increased capital revenues of $15.3 million, of which $4.9 million was related to the acquisitions of ATG UV and Frontier

51


Water Systems LLC, in addition to an increase in aftermarket revenues of $1.2 million, which was also partially driven by acquisitions.
Revenues from services increased $6.6 million, or 4.6%, to $149.5 million in the three months ended December 31, 2019 from $142.9 million in the three months ended December 31, 2018. This increase was driven by stronger organic service growth, which was augmented by price realization.
Cost of Sales and Gross Margin-Total gross margin increased to 30.5% in the three months ended December 31, 2019 from 27.5% in the three months ended December 31, 2018.
The following table provides the change in cost of product sales and cost of services, respectively, along with related gross margins:
 
Three Months Ended December 31,
 
2019
 
2018
 
 
 
Gross
Margin %
 
 
 
Gross
Margin %
Cost of product sales
$
(140.5
)
 
28.5
%
 
$
(136.6
)
 
24.2
%
Cost of services
(99.9
)
 
33.2
%
 
(97.7
)
 
31.6
%
 
$
(240.4
)
 
30.5
%
 
$
(234.3
)
 
27.5
%
Gross margin from product sales increased by 4.3% to 28.5% in the three months ended December 31, 2019 from 24.2% in the three months ended December 31, 2018. The increase in gross margin was primarily driven by costs incurred in the prior year of $4.3 million, mainly due to product rationalization, that did not reoccur in the current year. Remaining change is related to change in product mix and price realization.
Gross margin from services increased by approximately 1.6% to 33.2% in the three months ended December 31, 2019 from 31.6% in the three months ended December 31, 2018. These increases are mainly driven by price realization.
Operating Expenses-Operating expenses decreased $7.6 million, or 8.0%, to $87.5 million in the three months ended December 31, 2019 from $95.1 million in the three months ended December 31, 2018. Included in the three months ended December 31, 2019 was a gain from foreign currency translation of $6.4 million, whereas included in the three months ended December 31, 2018 amount was a loss from unfavorable foreign currency translation of $4.8 million, most of which is related to intercompany loans. This change in foreign currency resulted in a net decrease in operating expenses of $11.3 million period over period. Additionally, changes in the estimates of certain acquisitions achieving their earn-out targets resulted in another $2.5 million net reduction in operating expenses. These decreases were partially offset by increases in operating expenses of $2.5 million associated with the acquisitions of ATG UV and Frontier, transaction costs related to the sale of the Memcor product line of $1.0 million and additional employee related expenses of $1.5 million.
A discussion of operating expenses by category is as follows:
Research and Development Expense - Research and development expenses decreased $0.4 million during the three months ended December 31, 2019 as compared to December 31, 2018 due to the Company’s continued efforts to reduce spending, offset partially by increased expenses due to the Frontier acquisition.
Sales and Marketing Expense - Sales and marketing expenses had an increase of $1.8 million during the three months ended December 31, 2019 as compared to December 31, 2018, mainly due to the Frontier acquisition in addition to increased employee expenses.
General and Administrative Expense - General and administrative expenses decreased $9.0 million, or 16.4%, to $45.8 million in the three months ended December 31, 2019 from $54.8 million in the three months ended December 31, 2018. This decrease in general and administrative expenses was primarily due to the favorable change in foreign currency translation on the intercompany loans of $10.7 million, as described above, in addition to the decrease of $2.5 million of costs incurred in the prior year related to changes in the estimate of certain acquisitions achieving their earn-out targets. These decreases were partially offset by an increase of transaction

52


costs related to the sale of the Memcor product line of $1.0 million, additional employee related expenses of $1.1 million, and $0.9 million in expenses from the ATG UV and Frontier acquisitions.
Other operating income (expense)-Other operating income (expense) increased $51.5 million, to income of 51.5 million in the three months ended December 31, 2019 from income of $40.0 thousand in the three months ended December 31, 2018. The increase is mainly due to the net pre-tax benefit on sale of the Memcor product line of $49.0 million, which is net of $8.3 million of discretionary compensation payments to employees in connection with the transaction and $1.0 million in transaction costs incurred in the three months ended December 31, 2019.
Interest Expense-Interest expense decreased $0.8 million, or 5.6%, to $13.6 million in the three months ended December 31, 2019 from $14.4 million in the three months ended December 31, 2018. The decrease in interest expense was primarily driven by a reduction in LIBOR year over year, partially offset by additional borrowings.
Income tax (expense) benefit-An income tax expense of $2.6 million and an income tax benefit of $4.5 million was recorded for the three months ended December 31, 2019 and 2018, respectively. The increase in tax expense from the prior year was principally due to the significant income earned in the current year, primarily from the sale of the Memcor product line, as compared to a significant loss in the prior year.
Net Income-Net income increased by $69.8 million, or 428.2%, to $53.5 million for the three months ended December 31, 2019, from a net loss of $16.3 million in the three months ended December 31, 2018. The main driver of this increase is the sale of the Memcor product line, which resulted in a gain on sale of $58.3 million, less amounts paid for discretionary bonuses of $8.3 million and transaction costs of $1.0 million incurred in the three months ended December 31, 2019. The resulting net pre-tax benefit was $49.0 million. In addition to the net benefit of the sale, we saw overall contributions of revenue volume and mix of $17 million. Net income for the quarter also includes $6.4 million of foreign currency gain, mainly due to intercompany loans, versus a prior year period foreign currency loss of $4.8 million. These increases were offset by a $7.1 million net increase in income tax expense in the current year period based on the projected effective tax rate for the fiscal year.
Adjusted EBITDA-Adjusted EBITDA increased $5.2 million, or 13.5%, to $43.6 million for the three months ended December 31, 2019 from $38.4 million for the three months ended December 31, 2018. The increase in Adjusted EBITDA for the quarter as compared to the prior year period was primarily driven by the increased revenue volume, augmented by price realization and the favorable change in mix driven by higher service volumes.
Segment Results
 
Three Months Ended December 31,
 
2019
 
2018
 
% Variance
 
 
 
% of Revenue
 
 
 
% of Revenue
 
 
Revenues
 
 
 
 
 
 
 
 
 
Integrated Solutions and Services
$
228.1

 
65.9
 %
 
$
210.5

 
65.2
 %
 
8.4
 %
Applied Product Technologies
118.0

 
34.1
 %
 
112.5

 
34.8
 %
 
4.9
 %
Total Consolidated
346.1

 
100.0
 %
 
323.0

 
100.0
 %
 
7.2
 %
Operating profit (loss)
 
 
 
 
 
 
 
 
 
Integrated Solutions and Services
33.2

 
9.6
 %
 
27.9

 
8.6
 %
 
19.0
 %
Applied Product Technologies
63.1

 
18.2
 %
 
4.5

 
1.4
 %
 
1,302.2
 %
Corporate
(26.6
)
 
(7.7
)%
 
(38.8
)
 
(12.0
)%
 
(31.4
)%
Total Consolidated
69.7

 
20.1
 %
 
(6.4
)
 
(2.0
)%
 
(1,189.1
)%
EBITDA
 
 
 
 
 
 
 
 
 
Integrated Solutions and Services
48.8

 
14.1
 %
 
41.9

 
13.0
 %
 
16.5
 %
Applied Product Technologies
66.7

 
19.3
 %
 
8.9

 
2.8
 %
 
649.4
 %
Corporate and unallocated costs
(20.7
)
 
(6.0
)%
 
(34.1
)
 
(10.6
)%
 
(39.3
)%
Total Consolidated
$
94.8

 
27.4
 %
 
$
16.7

 
5.2
 %
 
467.7
 %



53


Adjusted EBITDA on a segment basis is defined as earnings before interest expense, income tax expense (benefit) and depreciation and amortization, adjusted for the impact of certain other items that have been reflected at the segment level. The following is a reconciliation of our segment operating profit to Adjusted EBITDA:
 
Three Months Ended December 31,
 
2019
 
2018
 
Integrated Solutions and Services
 
Applied Product Technologies
 
Integrated Solutions and Services
 
Applied Product Technologies
Operating Profit
$
33.2

 
$
63.1

 
$
27.9

 
$
4.5

Depreciation and amortization
15.6

 
3.6

 
14.0

 
4.4

EBITDA
$
48.8

 
$
66.7

 
$
41.9

 
$
8.9

Restructuring and related business transformation costs (a)

 
0.7

 
0.3

 
0.3

Transaction costs (b)

 
(1.3
)
 
0.5

 
0.7

Other losses (gains) and expenses (c)

 
(50.3
)
 
0.2

 
4.1

Adjusted EBITDA (d)
$
48.8

 
$
15.8

 
$
42.9

 
$
14.0

(a)
Represents costs and expenses in connection with restructuring initiatives distinct to our Integrated Solutions and Services and Applied Product Technologies segments in the three months ended December 31, 2019 and 2018, respectively. Such expenses are primarily composed of severance and relocation costs.
(b)
Represents costs associated with a change in the current estimate of certain acquisitions achieving their earn-out targets, which resulted in a (decrease) increase to the fair valued amount of the earn-out recorded upon acquisition, in the three months ended December 31, 2019 and 2018, respectively, distinct to our Integrated Solutions and Services and Applied Product Technologies segments.
(c)
Other losses, (gains) and expenses as discussed above in “How We Assess the Performance of Our Business-Adjusted EBITDA” distinct to our Integrated Solutions and Services and Applied Product Technologies segments include the following:
 
Three Months Ended December 31,
 
2019
 
2018
(In millions)
Integrated Solutions and Services
 
Applied Product Technologies
 
Integrated Solutions and Services
 
Applied Product Technologies
Net pre-tax benefit on sale of the Memcor product line
$

 
$
(49.0
)
 
$

 
$

Remediation of manufacturing defects

 
(1.4
)
 

 
1.0

Product rationalization in electro-chlorination business

 
0.1

 

 
3.1

Expenses related to maintaining non-operational business locations

 

 
0.2

 

Total
$

 
$
(50.3
)
 
$
0.2

 
$
4.1


(d)
For the definition of Adjusted EBITDA and a reconciliation to net income (loss), its most directly comparable financial measure presented in accordance with GAAP, see “How We Assess the Performance of Our Business-Adjusted EBITDA.”
Integrated Solutions and Services
Revenues in the Integrated Solutions and Services segment increased $17.6 million, or 8.4%, to $228.1 million in the three months ended December 31, 2019 from $210.5 million in the three months ended December 31, 2018. The increase in revenue was driven by stronger capital growth of $9.7 million, exclusive of acquisitions, and service growth of $6.8 million, which was augmented by price realization. Our recent investment in Frontier Water Systems LLC resulted in another increase of $1.3 million of revenue.

54


chart-57420ab7096e0007484.jpg
Operating profit in the Integrated Solutions and Services segment increased $5.3 million, or 19.0%, to $33.2 million in the three months ended December 31, 2019 from $27.9 million in the three months ended December 31, 2018. Segment profitability improved $7.3 million in the period driven by increased organic and acquisition related revenue volume, augmented by improved pricing, and favorable change in product mix driven by the higher service volumes. Profitability in the current year was also favorably impacted by the non-recurrence of $0.5 million of charges related to the achievement of earn-out targets associated with the Pure Water acquisition, in addition to the non-recurrence of other charges noted in the prior year of approximately $0.5 million related to restructuring and inactive sites. Negative drivers to profitability were increased employee related expenses of $1.4 million and higher depreciation and amortization expense of $1.6 million.
chart-5816c0aadde669bc8f1.jpg
EBITDA in the Integrated Solutions and Services segment increased $6.9 million, or 16.5%, to $48.8 million in the three months ended December 31, 2019, compared to $41.9 million in the three months ended December 31, 2018.
Applied Product Technologies
Revenues in the Applied Product Technologies segment increased $5.5 million, or 4.9%, to $118.0 million in the three months ended December 31, 2019 from $112.5 million in the three months ended December 31, 2018. Revenues grew $2.3 million due to increased aftermarket revenue and price realization. The acquisition of ATG UV contributed an increase in revenue of $3.9 million. These increases were partially offset unfavorable foreign currency translation impact of $0.7 million.

55


chart-238889fb7120a461be9.jpg
Operating profit in the Applied Product Technologies segment increased $58.6 million, or 1,302.2%, to $63.1 million in the three months ended December 31, 2019 from $4.5 million in the three months ended December 31, 2018. The increase is mainly due to the net pre-tax benefit on sale of the Memcor product line of $49.0 million, which is net of $8.3 million of discretionary compensation payments to employees in connection with the transaction and $1.0 million in transaction costs incurred in the three months ended December 31, 2019. Increased profit was also driven by volume and mix performance, augmented by improved pricing, of $1.8 million, in addition to lower depreciation of $0.8 million and $0.6 million from the acquisition of ATG UV. Further increases were due to one time reductions in costs of $7.0 million related to:

A net recovery of costs incurred by the Company from a settlement with a third-party vendor associated with remediation of manufacturing defects caused by the vendor of $1.4 million as compared to prior year expense of $1.0 million
Reductions in costs related to the achievement of earn-out targets associated with certain acquisitions of $1.3 million as compared to prior year expense of $0.7 million
Reductions in other non-recurring costs by $2.6 million

Operating profit was reduced by $0.6 million, net as compared to the prior period as the increased benefits from the two segment realignment resulting in cost savings of $1.4 million as compared to the same period in the prior year were offset by increased employment costs related to inflation and incentive of $2.0 million.
chart-a7dd26d3f34b733ae3b.jpg
EBITDA in the Applied Product Technologies segment increased $57.8 million, or 649.4%, to $66.7 million in the three months ended December 31, 2019, compared to $8.9 million in the three months ended December 31, 2018.

56


Liquidity and Capital Resources
Liquidity describes the ability of a company to generate sufficient cash flows to meet the cash requirements of its business operations, including working capital needs, debt service, acquisitions, other commitments and contractual obligations. We consider liquidity in terms of cash flows from operations and their sufficiency to fund our operating and investing activities.
Our principal sources of liquidity are our cash generated by operating activities and borrowings under our Revolving Credit Facility. Historically, we have financed our operations primarily from cash generated from operations and periodic borrowings under our $125.0 million Revolving Credit Facility. Our primary cash needs are for day to day operations, to pay interest and principal on our indebtedness, to fund working capital requirements and to make capital expenditures.
We expect to continue to finance our liquidity requirements through internally generated funds, borrowings under our Revolving Credit Facility and equipment financing arrangements. We believe that our projected cash flows generated from operations, together with borrowings under our Revolving Credit Facility and other financing arrangements are sufficient to fund our principal debt payments, interest expense, our working capital needs and our expected capital expenditures for the next twelve months. Our capital expenditures for the three months ended December 31, 2019 and 2018 were $17.6 million and $17.6 million, respectively. However, our budgeted capital expenditures can vary from period to period based on the nature of capital intensive project awards. From time to time, we may enter into financing arrangements related to capital expenditures for equipment used to provide services to our customers. In addition, we may draw on our Revolving Credit Facility from time to time to fund or partially fund an acquisition.
As of December 31, 2019, we had total indebtedness of $976.9 million, including $926.4 million of borrowings under the First Lien Term Loan Facility, no borrowings under our Revolving Credit Facility, $48.1 million in borrowings related to equipment financing, $0.8 million of notes payable related to certain equipment related contracts and $1.7 million related to a mortgage. We also had $13.1 million of letters of credit issued under our $125.0 million Revolving Credit Facility and an additional $0.2 million of letters of credit issued under a separate uncommitted facility as of December 31, 2019.
Our senior secured credit facilities contain a number of covenants imposing certain restrictions on our business. These restrictions may affect our ability to operate our business and may limit our ability to take advantage of potential business opportunities as they arise. The restrictions these covenants place on our business operations, include limitations on our or our subsidiaries’ ability to:
incur or guarantee additional indebtedness;
make certain investments;
pay dividends or make distributions on our capital stock;
sell assets, including capital stock of restricted subsidiaries;
agree to payment restrictions affecting our restricted subsidiaries;
consolidate, merge, sell or otherwise dispose of all or substantially all of our assets;
enter into transactions with our affiliates;
incur liens; or
designate any of our subsidiaries as unrestricted subsidiaries.
We are a holding company and do not conduct any business operations of our own. As a result, our ability to pay cash dividends on our common stock, if any, is dependent upon cash dividends and distributions and other transfers from our operating subsidiaries. Under the terms of our senior secured credit facilities, our operating subsidiaries are currently limited in their ability to pay cash dividends to us, and we expect these limitations to continue in the future under the terms of any future credit agreement or any future debt or preferred equity securities of ours or of our subsidiaries.
In addition, our Revolving Credit Facility, but not the First Lien Term Loan Facility, contains a financial covenant which requires us to comply with the maximum first lien net leverage ratio of 5.55 to 1.00 as of the last day of any quarter

57


on which the aggregate amount of revolving loans and letters of credit outstanding under the Revolving Credit Facility (net of cash collateralized letters of credit and undrawn outstanding letters of credit in an amount of up to 50% of the Revolving Credit Facility) exceeds 25% of the total commitments thereunder.
As of December 31, and September 30, 2019, we were in compliance with the covenants contained in the senior secured credit facilities.
Our indebtedness could adversely affect our ability to raise additional capital, limit our ability to react to changes in the economy or our industry, expose us to interest rate risk and prevent us from meeting our obligations.
Cash Flows
The following table summarizes the changes to our cash flows for the periods presented:
 
Three Months Ended
December 31,
(In millions)
2019
 
2018
Statement of Cash Flows Data
 
Net cash provided by operating activities
$
4.7

 
$
4.1

Net cash provided by (used in) investing activities
80.2

 
(17.7
)
Net cash used in financing activities
(1.8
)
 
(4.9
)
Effect of exchange rate changes on cash
1.9

 
(0.7
)
Change in cash and cash equivalents
$
85.0

 
$
(19.2
)
Operating Activities
Cash flows from operating activities can fluctuate significantly from period‑to‑period as working capital needs and the timing of payments for restructuring activities and other items impact reported cash flows.
Net cash provided by operating activities increased to a source of $4.7 million in the three months ended December 31, 2019 from a source of $4.1 million in the three months ended December 31, 2018.
Operating cash flows in the three months ended December 31, 2019 reflect an increase in net earnings of $69.8 million as compared to the three months ended December 31, 2018.
Non‑cash items reduced operating cash flows by $35.3 million in the three months ended December 31, 2019 as compared to an increase to operating cash flows of $32.0 million in the three months ended December 31, 2018, resulting an an overall reduction of $67.3 million. This reduction was primarily driven by the adjustment for gain on sale of business, offset by an increase in depreciation and amortization expense. Non-cash changes also include the foreign currency translation gain.
The aggregate of receivables, inventories, contract assets and liabilities and accounts payable used $6.9 million in operating cash flows in the three months ended December 31, 2019 compared to a use of $2.6 million in operating cash flows in the three months ended December 31, 2018. The amount of cash flow generated from or used by the above mentioned accounts depends upon how effectively we manage our cash conversion cycle, which is a representation of the number of days that elapse from the date of purchase of raw materials and components to the collection of cash from customers. Our cash conversion cycle can be significantly impacted by the timing of collections and payments in a period.
The aggregate of prepaid expense and other current assets, income taxes and other non current assets and liabilities provided $2.8 million in operating cash flows in the three months ended December 31, 2019 compared to $1.3 million provided in the three months ended December 31, 2018. This is mainly due to timing of payments.

58


Accrued expenses and other liabilities used $9.4 million in operating cash flows in the three months ended December 31, 2019 compared to a use of $15.4 million in the three months ended December 31, 2018.
chart-c03739482c62a02b011a01.jpg
Investing Activities
Net cash provided by investing activities increased $97.9 million to $80.2 million in the three months ended December 31, 2019 from a use of $17.7 million in the three months ended December 31, 2018. This increase was largely driven by proceeds from the sale of the Memcor product line during the three months ended December 31, 2019, partially offset by lower cash outflow associated with the Frontier acquisition in the current year period. Other activity related to purchase of capital or intangible assets remained relatively consistent with the prior period.
Financing Activities
Net cash used in financing activities decreased $3.1 million to a use of $1.8 million in the three months ended December 31, 2019 from a use of $4.9 million in the three months ended December 31, 2018. This lower amount of cash used in financing activities for the three months ended December 31, 2019 was primarily due to the cash received from common stock activity which was offset by increased distribution of dividends to non-controlling interest.
Seasonality
Our business may exhibit seasonality resulting from our customers’ increasing demand for our products and services during the spring and summer months as compared to the fall and winter months. For example, our business servicing municipal customers experiences increased demand for our odor control product lines and services in the warmer months which, together with other factors, typically results in improved performance in the second half of our fiscal year. Inclement weather, such as hurricanes, droughts and floods, can also drive increased demand for our products and services. As a result, our results from operations may vary from period to period.

Off‑Balance Sheet Arrangements
As of December 31, and September 30, 2019, we had letters of credit totaling $13.3 million and $13.0 million, respectively, and surety bonds totaling $154.1 million and $144.7 million, respectively, outstanding under our credit arrangements. The longest maturity date of the letters of credit and surety bonds in effect as of December 31, 2019 was March 26, 2029.

59


Critical Accounting Policies and Estimates
See Note 2, “Summary of Significant Accounting Policies” in the Unaudited Consolidated Financial Statements in Item 1 of this Report for a complete discussion of our significant accounting policies and recent accounting pronouncements.
Item 3. Quantitative and Qualitative Disclosures about Market Risk
    We have market risk exposure arising from changes in interest rates on our senior secured credit facilities, which bear interest at rates that are benchmarked against LIBOR. In November 2018, the Company entered into an interest rate cap to mitigate risks associated with variable rate debt. The LIBOR interest rate cap has a notional value of $600 million, is effective for a period of three years and has a strike price of 3.5%.
Based on our overall interest rate exposure to variable rate debt outstanding as of December 31, 2019, a 1% increase or decrease in interest rates would decrease or increase income (loss) before income taxes by approximately $9.3 million. By comparison, based on our overall interest rate exposure to variable rate debt outstanding as of December 31, 2018, a 1% increase or decrease in interest rates would have decreased or increased income (loss) before income taxes by approximately $9.4 million.
For a discussion of the Company’s exposure to market risk related to inflation, tariffs and foreign currency exchange rates, please refer to Part II, Item 7A, “Quantitative and Qualitative Disclosures About Market Risk,” of our Annual Report on Form 10-K for the fiscal year ended September 30, 2019, as filed with the SEC on November 25, 2019. There have been no material changes to the Company’s exposure to these market risks during the first quarter of fiscal 2020.
Item 4.    Controls and Procedures.
Evaluation of Disclosure Controls and Procedures
           Our disclosure controls and procedures (as defined in Rules 13a-15(e) or 15d-15(e) under the Securities Exchange Act of 1934, as amended) are designed to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission and to ensure that information required to be disclosed is accumulated and communicated to management, including our principal executive and financial officers, to allow timely decisions regarding disclosure. Our management has evaluated, under the supervision and with the participation of our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), the effectiveness of our disclosure controls and procedures as of the end of the period covered by this Report and, based on their evaluation, have concluded that the disclosure controls and procedures were effective as of such date.
 
While our disclosure controls and procedures are designed to provide reasonable assurance of their effectiveness, because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected.

Changes to Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting that occurred during the quarterly period ended December 31, 2019 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.






60


Part II - Other Information

Item 1. Legal Proceedings
From time to time, we are subject to various claims, charges and litigation matters that arise in the ordinary course of business. We believe these actions are a normal incident of the nature and kind of business in which we are engaged. While it is not feasible to predict the outcome of these matters with certainty, we do not believe that any asserted or unasserted legal claims or proceedings, individually or in the aggregate, will have a material adverse effect on our business, financial condition, results of operations or prospects.

On or around November 6, 2018, a purported shareholder of the Company filed a class action lawsuit in the U.S. District Court for the Southern District of New York, captioned McWilliams v. Evoqua Water Technologies Corp., et al., Case No. 1:18-CV-10320, alleging that the Company and senior management violated federal securities laws.  On January 31, 2019, the court appointed lead plaintiffs and lead counsel in connection with the action and captioned the action “In re Evoqua Water Technologies Corp. Securities Litigation,” Master File No. 1:18-CV-10320. On March 28, 2019, lead plaintiffs filed an amended complaint, which asserts claims pursuant to the Securities Exchange Act of 1934 and the Securities Act of 1933 against the Company, members of the Company’s Board of Directors, senior management, other executives and/or employees, AEA Investors LP and a number of its affiliated entities, and the underwriters of the Company’s initial public offering and secondary public offering. The amended complaint alleges that the defendants violated federal securities laws by issuing false, misleading, and/or omissive disclosures concerning the Company’s integration of acquired companies, the Company’s reduction-in-force, and the Company’s accounting practices. The lawsuit seeks compensatory damages in an unspecified amount to be proved at trial, an award of reasonable costs and expenses to the plaintiff and class counsel, and such other relief as the court may deem just and proper.  On June 26, 2019, the defendants filed motions to dismiss the amended complaint. Briefing in connection with the motions to dismiss was completed on October 4, 2019. The Company believes that this lawsuit is without merit and intends to vigorously defend itself against the allegations.

On or around April 10, 2019, a purported shareholder of the Company filed a shareholder derivative lawsuit ostensibly on behalf of the Company in the U.S. District Court for the Western District of Pennsylvania, captioned Dallas Torgersen, derivatively on behalf of Evoqua Water Technologies Corp. v. Ronald C. Keating, et al., Case No. 2:19-CV-410. The complaint names as defendants the Company’s CEO, the Company’s CFO, and members of the Company’s Board of Directors, and it names the Company as a nominal defendant. The complaint alleges, among other things, that the individual defendants violated federal securities laws by issuing false, misleading, and/or omissive disclosures in the period leading up to the Company’s October 30, 2018 disclosure and that they breached their fiduciary duties to the Company. The lawsuit seeks compensatory damages in an unspecified amount to be proved at trial, an award of reasonable costs and expenses, restitution from the individual defendants, an order directing the Company and the individual defendants to take all necessary actions to reform and improve the Company’s corporate governance and internal procedures to comply with the law and to prevent the events alleged from reoccurring, including by putting forth for shareholder vote certain resolutions for amendments to the Company’s charter or bylaws, and such other relief as the court may deem just and proper. On June 14, 2019, the Court entered an order staying the lawsuit pending resolution of the In re Evoqua Water Technologies Corp. Securities Litigation lawsuit described above. The Company believes that this lawsuit is without merit and intends to vigorously defend itself against the allegations.

Item 1A. Risk Factors
There have been no material changes to the information concerning risk factors as stated in our Annual Report on Form 10-K for the fiscal year ended September 30, 2019, as filed with the SEC on November 25, 2019.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
None.

Item 3.    Defaults Upon Senior Securities

61


None.

Item 4.    Mine Safety Disclosures
None.

Item 5.    Other Information
None.


62


Item 6.    Exhibits
The following exhibits are filed or furnished as a part of this report:

Exhibit
No.
Exhibit Description
2.1

2.2

10.1

10.2

10.3

31.1*

31.2*

32.1*

32.2*

101.INS*

XBRL Instance Document.
101.SCH*

XBRL Taxonomy Extension Schema Document.
101.CAL*

XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF*

XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB*

XBRL Taxonomy Extension Label Linkbase Document.
101.PRE*

XBRL Taxonomy Extension Presentation Linkbase Document.
*



63




SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
 
EVOQUA WATER TECHNOLOGIES CORP.
 
 
 
 
 
 
 
 
 
 
 
By:
 
 
Chief Executive Officer (Principal Executive Officer)
 
 
 
 
 
 
 
 
 
 
 
By:
 
 
Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)
 
 
 







64

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
7/5/29
3/26/29
6/30/28
12/20/24
6/30/24
3/30/24
7/31/23
2/28/21
1/1/21
12/31/20
9/30/20
Filed on:2/4/208-K
1/31/20
For Period end:12/31/19SD
11/25/1910-K
11/2/194
10/4/19
10/1/19
9/30/1910-K,  10-K/A
6/26/19
6/14/19
4/10/19
3/28/19
1/31/19
12/31/1810-Q
12/21/18S-8
11/28/18
11/6/18
10/30/188-K
10/1/18
9/30/1810-K
6/29/18
3/21/184
3/19/184
11/7/174
11/6/174
4/1/15
1/16/14
1/15/14
10/7/13
 List all Filings 


5 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/10/21  Evoqua Water Technologies Corp.   424B3                  1:483K                                   Toppan Merrill/FA
12/03/20  Evoqua Water Technologies Corp.   424B3                  1:343K                                   Toppan Merrill-FA
12/01/20  Evoqua Water Technologies Corp.   424B3                  1:338K                                   Toppan Merrill-FA
 8/07/20  Evoqua Water Technologies Corp.   424B3       8/07/20    1:346K                                   Toppan Merrill-FA
 8/06/20  Evoqua Water Technologies Corp.   424B3                  1:342K                                   Toppan Merrill-FA
Top
Filing Submission 0001604643-20-000008   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Mar. 29, 1:57:05.1am ET